Infective dermatitis

L12_INFECT_DERM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L30.3 Cause of death: ICD-10 — L30.3 2 out of 7 registries used, show all original rules.	4865
4. Check minimum number of events None	4865
5. Include endpoints None	4865
6. Filter based on genotype QC (FinnGen only)	4865

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L30
Name in latin: Dermatitis infectiosa

NAME	L12_INFECT_DERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L303
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L303
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infective dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38784	18479	20130
Only index persons	35334	17298	18036
Unadjusted period prevalence (%)
Whole population	0.54	0.53	0.56
Only index persons	0.66	0.64	0.69
Median age at first event (years)
Whole population	52.86	51.94	53.63
Only index persons	52.28	51.57	52.96

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4865	2512	2353
Unadjusted period prevalence (%)	0.94	0.86	1.04
Median age at first event (years)	54.70	51.16	58.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4351: Matched controls
43509

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

323.0

440

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

12.3

323.0

1115

1187

D07AC13

ATC

mometasone; topical

6.6

323.0

2374

6687

E0000UV

ATC

8.4

323.0

3057

9516

L20.0

ICD-10 Finland

Besnier prurigo

+∞

323.0

690

D07AD01

ATC

clobetasol; topical

7.6

323.0

1574

3008

D09AB01

ATC

zinc bandage without supplements; topical

33.9

323.0

441

144

XQ802

NOMESCO Finland

Epicutan test

79.1

323.0

727

110

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.5

323.0

874

1409

D07AB02

ATC

hydrocortisone butyrate; topical

4.5

323.0

1891

6405

TQW80

NOMESCO Finland

Local dermatologic skincare

27.3

323.0

470

192

D07AB08

ATC

desonide; topical

8.2

323.0

995

1513

D07BC01

ATC

betamethasone and antiseptics; topical

8.5

323.0

1356

2197

L30.3

ICD-10 Finland

Infective dermatitis

+∞

323.0

4351

136

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

8.2

323.0

1338

2238

L30.0

ICD-10 Finland

Nummular dermatitis

27.7

323.0

711

304

E000001

ATC

7.6

323.0

1913

4082

D07AC01

ATC

betamethasone; topical

9.1

323.0

2950

8197

D07CC01

ATC

betamethasone and antibiotics; topical

5.6

323.0

1148

2613

L30.9

ICD-10 Finland

Dermatitis, unspecified

15.7

323.0

2006

2243

E000002

ATC

7.0

323.0

1045

1888

D07BA04

ATC

hydrocortisone and antiseptics; topical

5.8

266.6

836

1700

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

48.7

256.0

313

H02AB06

ATC

prednisolone; systemic

3.0

254.3

2496

13465

E000003

ATC

10.5

254.0

522

557

D02AE01

ATC

carbamide; topical

7.0

229.5

610

985

E000006

ATC

6.6

224.9

626

1076

D07XC01

ATC

betamethasone, combinations; topical

4.5

220.9

892

2355

D07AA02

ATC

hydrocortisone; topical

4.4

218.3

901

2428

XQ800

NOMESCO Finland

Prick test

6.8

205.2

558

923

E000007

ATC

7.2

179.6

466

716

J01DB01

ATC

cefalexin; oral

3.0

166.1

3735

29055

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

165.7

158

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.9

160.9

1259

5433

R06AE07

ATC

cetirizine; oral

2.4

160.3

2085

11984

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

1629.4

158.2

153

A46

ICD-10 Finland

Erysipelas

3.3

145.5

854

3000

L20

ICD-10 Finland

Atopic dermatitis

+∞

140.4

134

L30.8

ICD-10 Finland

Other specified dermatitis

15.8

125.6

210

139

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

186.8

122.1

127

D02AX

ATC

Other emollients and protectives

8.6

119.7

272

336

D07AC14

ATC

methylprednisolone aceponate; topical

5.6

114.1

353

672

L28.1

ICD-10 Finland

Prurigo nodularis

152.9

112.8

119

J01DA01

ATC

[U] cefalexin; systemic

2.1

110.2

2826

20555

D05BB02

ATC

acitretin; oral

9.6

110.1

233

254

R06AX27

ATC

desloratadine; oral

2.3

108.3

1259

6502

L40.0

ICD-10 Finland

Psoriasis vulgaris

5.7

107.9

331

623

N05BB01

ATC

hydroxyzine; systemic

4.4

106.9

420

1034

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

164.1

106.7

112

J01FF01

ATC

clindamycin; systemic

2.2

106.5

1348

7241

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

62.7

104.5

122

E000004

ATC

10.5

102.5

206

204

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

123.0

100.4

108

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

98.3

R06AE09

ATC

levocetirizine; oral

2.8

95.8

722

2922

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

84.4

95.5

107

D11AH01

ATC

tacrolimus; topical

320.5

94.3

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.7

90.1

681

2752

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

10.7

81.7

162

156

XQ848

NOMESCO Finland

Dermatological photography

7.5

81.2

200

279

S87

ICPC

Dermatitis/atopic eczema

8.7

78.4

175

209

D05AX52

ATC

calcipotriol, combinations; topical

3.9

74.6

331

903

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

77.0

73.3

L28.0

ICD-10 Finland

Lichen simplex chronicus

28.4

73.0

100

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

71.5

656

2928

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

79.5

69.2

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

67.9

SPAT1263

SPAT

Sampling

1.8

67.8

1841

12688

D07AB01

ATC

clobetasone; topical

5.3

66.2

212

417

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

6.6

66.0

177

279

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

65.3

654

3042

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.9

63.8

1197

7247

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.7

60.7

460

1833

S29

ICPC

Skin symptom/complaint other

2.1

59.7

740

3790

B35.3

ICD-10 Finland

Tinea pedis

4.2

59.2

239

597

D11AX14

ATC

[U] tacrolimus; topical

+∞

57.4

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

57.4

S97

ICPC

Chronic ulcer skin

3.4

57.1

297

919

SPAT1301

SPAT

No procedures

1.8

56.9

1357

8839

D07XB05

ATC

dexamethasone, combinations; topical

5.4

56.7

178

342

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

51.5

55.0

C03CA01

ATC

furosemide; systemic

1.8

54.1

1122

6960

L29.9

ICD-10 Finland

Pruritus, unspecified

8.3

53.8

122

150

J01AA07

ATC

tetracycline; systemic

2.1

53.7

677

3475

J01AA04

ATC

lymecycline; systemic

2.2

52.6

605

2983

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

493.3

49.5

S76

ICPC

Skin infection other

3.3

48.6

263

837

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

48.0

1761

12828

S21

ICPC

Skin texture symptom/complaint

2.2

47.8

536

2602

R06AX22

ATC

ebastine; oral

2.0

47.3

682

3686

S18

ICPC

Laceration/cut

1.6

47.1

1686

12177

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.4

46.5

446

2009

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

46.4

193

495

L50.3

ICD-10 Finland

Dermatographic urticaria

7.5

46.2

112

153

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

45.9

R03AC02

ATC

salbutamol; inhalant

1.6

45.5

2063

15791

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

44.5

703

3927

H02AB04

ATC

methylprednisolone; systemic

2.0

44.3

605

3192

SPAT1260

SPAT

Consultation of another employee

1.9

43.5

753

4344

SPAT1312

SPAT

General health counselling

1.6

42.8

1312

9031

D07CB01

ATC

triamcinolone and antibiotics; topical

5.3

42.7

134

258

N02BE01

ATC

paracetamol; systemic, rectal

1.7

42.3

3534

31235

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

42.1

246

827

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.5

42.0

210

629

L04AD01

ATC

ciclosporin; systemic

5.6

40.9

123

225

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

40.7

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

11.7

40.1

SPAT1310

SPAT

Counselling related to known health issue

1.6

39.6

1290

8981

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.1

39.6

128

255

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

39.0

935

5971

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

38.9

325

1358

D11AH04

ATC

alitretinoin; oral

201.8

38.9

L08.0

ICD-10 Finland

Pyoderma

9.9

38.8

J01CF05

ATC

flucloxacillin; systemic

3.3

38.0

203

640

D05AX02

ATC

calcipotriol; topical

3.2

37.9

205

653

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

37.7

746

4481

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

37.4

1232

8578

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

37.4

1119

7596

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

37.3

1591

11801

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

191.6

36.8

D01AC02

ATC

miconazole; topical

2.3

35.5

356

1632

B86

ICD-10 Finland

Scabies

6.1

35.4

166

S06

ICPC

Rash localized

2.8

35.2

233

849

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.6

34.6

123

272

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

34.1

537

2976

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

33.0

341

1585

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

32.9

399

1991

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

32.6

1623

12362

S01

ICPC

Pain/tenderness of skin

2.9

32.2

203

719

S02

ICPC

Pruritus

3.5

31.9

156

461

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.1

31.8

146

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

31.7

1576

11982

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

31.5

440

2326

L40.9

ICD-10 Finland

Psoriasis, unspecified

5.6

31.4

172

SPAT1153

SPAT

Removal of sutures

1.5

31.2

1247

9021

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

30.9

365

1801

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.1

30.8

108

L04AX01

ATC

azathioprine; systemic

2.8

30.2

199

724

UJF32

NOMESCO Finland

Coloscopy

1.6

30.2

979

6724

SPAT1262

SPAT

Handing over of treatment supplies

1.7

30.0

736

4689

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

30.0

1089

7689

R06AX13

ATC

loratadine; oral

1.8

30.0

563

3306

N02AX02

ATC

tramadol; systemic, rectal

1.5

30.0

1600

12305

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

304.4

29.8

S88

ICPC

Dermatitis contact/allergic

4.4

29.4

108

248

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

29.2

1027

7187

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

6.1

29.0

133

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

28.9

440

2399

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

28.6

527

3074

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

28.3

2180

17954

D11AH02

ATC

pimecrolimus; topical

+∞

28.1

S99

ICPC

Skin disease other

4.4

28.1

105

245

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

28.0

1141

8249

WZC30

NOMESCO Finland

Teaching

1.8

27.9

519

3033

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

27.8

303

1440

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

27.7

872

5927

L04AA01

ATC

[U] ciclosporin; systemic

5.3

27.6

166

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

27.5

185

683

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

27.4

314

1527

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

27.3

517

3037

R06.0

ICD-10 Finland

Dyspnoea

1.6

27.0

901

6208

D01AE15

ATC

terbinafine; topical

2.2

26.7

291

1382

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

26.4

1005

7138

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

9.7

26.1

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

26.1

915

6371

M79.6

ICD-10 Finland

Pain in limb

1.5

25.6

1302

9829

N07BA03

ATC

varenicline; oral

2.4

25.6

226

970

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

25.6

557

3417

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.1

25.4

102

256

L17

ICPC

Foot/toe symptom/complaint

1.5

25.3

909

6357

SPAT1255

SPAT

Intravenous administration of medicine

2.2

25.3

271

1278

D01BA02

ATC

terbinafine; oral; topical

1.5

25.2

942

6652

D11AX15

ATC

[U] pimecrolimus; topical

+∞

25.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.4

25.0

208

WQ021

NOMESCO Finland

39.0

24.9

C09AA02

ATC

enalapril; systemic

1.6

24.8

729

4855

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

24.8

652

4213

J01DB05

ATC

cefadroxil; oral

2.5

24.7

194

784

L29.8

ICD-10 Finland

Other pruritus

8.1

24.3

J04BA02

ATC

dapsone; oral

11.1

24.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

24.1

1045

7611

R03BB04

ATC

tiotropium bromide; inhalant

1.9

24.1

378

2080

R50.9

ICD-10 Finland

Fever, unspecified

1.7

24.0

512

3116

J01MA02

ATC

ciprofloxacin; systemic

1.4

24.0

1438

11175

L21.0

ICD-10 Finland

Seborrhoea capitis

8.6

24.0

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

23.9

464

2742

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

23.8

143

491

R02

ICPC

Shortness of breath/dyspnoea

1.8

23.7

442

2580

L30.4

ICD-10 Finland

Erythema intertrigo

6.2

23.7

104

H02AB07

ATC

prednisone; oral

1.7

23.5

515

3158

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

22.9

R60.0

ICD-10 Finland

Localized oedema

1.8

22.9

392

2220

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

22.8

423

2462

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

22.6

775

5347

J01FA06

ATC

roxithromycin; oral

1.4

22.5

1470

11579

A02BC02

ATC

pantoprazole; systemic

1.4

22.5

2458

21146

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

9.1

22.5

T90

ICPC

Diabetes non-insulin dependent

1.5

22.2

842

5941

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

22.1

495

3052

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

21.9

C07AB07

ATC

bisoprolol; oral

1.4

21.7

1719

13980

D05AX03

ATC

calcitriol; topical

5.0

21.6

142

134

Kela drug reimbursment

General erythroderma

14.5

21.6

J01MA14

ATC

moxifloxacin; systemic

1.9

21.3

336

1849

J01MA12

ATC

levofloxacin; systemic

1.6

21.1

663

4474

205

Kela drug reimbursment

Chronic hypertension

1.5

21.1

1002

7410

WQ007

NOMESCO Finland

60.3

20.9

L27.2

ICD-10 Finland

Dermatitis due to ingested food

+∞

20.8

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

10.1

20.8

N03AX12

ATC

gabapentin; oral

1.6

20.8

551

3560

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

20.7

292

1542

L73.8

ICD-10 Finland

Other specified follicular disorders

6.2

20.7

L28.2

ICD-10 Finland

Other prurigo

25.6

20.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

20.3

663

4514

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

20.1

170

714

SPAT1211

SPAT

Application of soft bandage

1.8

20.1

341

1925

N05AH04

ATC

quetiapine; oral

1.6

20.0

576

3796

J01AA02

ATC

doxycycline; systemic

1.4

20.0

3030

27216

ZZA00

NOMESCO Finland

Split skin graft

2.8

19.8

126

452

N05CF01

ATC

zopiclone; oral

1.4

19.7

1144

8773

L13.0

ICD-10 Finland

Dermatitis herpetiformis

13.2

19.6

J01XC01

ATC

fusidic acid; systemic

4.2

19.6

177

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

19.5

155

632

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

19.5

352

2032

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

19.4

1700

13972

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

4.8

19.1

136

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

18.9

555

3676

L30

ICD-10 Finland

Other dermatitis

3.8

18.8

218

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

18.7

246

1264

N03AX16

ATC

pregabalin; oral

1.5

18.7

826

6001

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

18.6

198

930

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

18.6

149

610

D07AC03

ATC

desoximetasone; topical

3.7

18.5

226

WIX00

NOMESCO Finland

Allergy cleanup guidance

38.5

18.5

R03BA05

ATC

fluticasone; inhalant

1.5

18.5

623

4266

SPAT1254

SPAT

Administration of medicine

1.6

18.4

512

3344

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

18.4

108

368

G47.3

ICD-10 Finland

Sleep apnoea

1.5

18.3

765

5488

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

18.1

106

361

AA1AD

NOMESCO Finland

CT of head and brain

1.4

18.1

846

6211

C08CA01

ATC

amlodipine; oral

1.4

18.1

1249

9845

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

18.0

745

5332

E0001A1

ATC

3.5

18.0

237

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

18.0

253

A10BA02

ATC

metformin; oral

1.4

17.9

991

7510

R4180

NOMESCO Finland

Podiatric therapy

4.8

17.8

124

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.1

17.7

327

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

17.7

375

2270

N06AX11

ATC

mirtazapine; oral

1.4

17.6

1104

8549

WQ020

NOMESCO Finland

36.8

17.6

A10AE05

ATC

insulin detemir; parenteral

2.1

17.5

213

1061

C03DA01

ATC

spironolactone; oral

1.7

17.5

363

2185

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

17.5

2393

20914

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.4

1237

9780

L84

ICD-10 Finland

Corns and callosities

2.6

17.3

131

522

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

17.2

556

3761

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.8

17.1

111

404

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.8

17.1

114

421

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

17.1

499

3298

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

50.2

17.0

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.9

2085

17908

D01AC03

ATC

econazole; topical

2.0

16.9

230

1200

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

16.9

334

1982

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

16.9

308

1783

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

16.8

280

1568

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

16.8

128

512

M04AA01

ATC

allopurinol; systemic

1.6

16.7

453

2935

N06AX21

ATC

duloxetine; oral

1.7

16.7

364

2220

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

16.7

409

2579

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

16.6

162

734

M54.5

ICD-10 Finland

Low back pain

1.4

16.6

1124

8804

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

16.6

1751

14694

-1

NOMESCO Finland

1.4

16.6

1183

9345

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.3

16.5

148

646

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

16.3

274

1542

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

16.1

232

1236

N02AA05

ATC

oxycodone; systemic

1.6

16.1

487

3242

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

16.0

345

2099

WXQ24

NOMESCO Finland

UVB/UVA light therapy

47.7

16.0

L04AB04

ATC

adalimumab; parenteral

3.3

16.0

245

B01AC04

ATC

clopidogrel; oral

1.5

15.8

541

3708

A02BC01

ATC

omeprazole; systemic

1.4

15.7

970

7472

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

15.6

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

15.6

930

7113

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

15.6

286

1657

F10.24

ICD-10 Finland

Alcohol depence active use

3.7

15.6

187

ICD-10 Finland

2.8

15.5

102

375

A10AE04

ATC

insulin glargine; parenteral

1.7

15.5

339

2072

L04AA06

ATC

mycophenolic acid; systemic

3.3

15.4

230

L85.3

ICD-10 Finland

Xerosis cutis

5.1

15.4

WX290

NOMESCO Finland

Other blockade of nerve

1.3

15.3

1566

13032

J02AC01

ATC

fluconazole; systemic

1.3

15.3

1338

10882

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

15.2

253

1419

L50.0

ICD-10 Finland

Allergic urticaria

3.0

15.2

292

A02BC03

ATC

lansoprazole; oral

1.4

15.1

1014

7912

SPAT1151

SPAT

Treatment of major wounds

3.9

15.1

157

R03BA01

ATC

beclometasone; inhalant

1.5

15.1

471

3161

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

14.9

244

1362

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

14.9

278

1621

L03

ICPC

Low back symptom/complaint

1.4

14.8

790

5923

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

14.7

1152

9204

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

10.4

14.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

14.6

559

3923

R03DC03

ATC

montelukast; oral

1.5

14.6

511

3518

L12.0

ICD-10 Finland

Bullous pemphigoid

7.3

14.4

I50.0

ICD-10 Finland

Congestive heart failure

1.8

14.4

232

1287

SPAT1058

SPAT

PEF monitoring instruction

1.7

14.4

296

1775

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

14.4

125

536

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

14.4

358

2266

KMAK

NOMESCO Finland

1.3

14.4

1895

16290

R53

ICD-10 Finland

Malaise and fatigue

1.4

14.4

671

4900

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

14.4

271

1582

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

14.3

105

411

J02AC02

ATC

itraconazole; systemic

1.5

14.2

608

4363

B01AB05

ATC

enoxaparin; parenteral

1.3

14.2

1054

8343

P01AB01

ATC

metronidazole; oral, rectal

1.3

14.0

1373

11323

N06AA09

ATC

amitriptyline; systemic

1.6

13.9

334

2093

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

13.9

260

WZA90

NOMESCO Finland

Other doctors statement

1.4

13.9

795

6026

J01FA01

ATC

erythromycin; systemic

1.5

13.9

466

3178

UDC00

NOMESCO Finland

Ear microscopy

1.8

13.8

252

1459

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

13.7

995

7842

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.8

13.7

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

13.7

267

1577

R05

ICPC

Cough

1.4

13.7

742

5569

SPAT1229

SPAT

Assessment of need for aid

1.7

13.7

262

1540

N05AX08

ATC

risperidone; systemic

1.7

13.6

261

1531

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

13.6

287

1735

L40

ICD-10 Finland

Psoriasis

3.3

13.6

209

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

13.6

2622

23604

R96

ICPC

Asthma

1.7

13.5

286

1730

SPAT1240

SPAT

Therapeutic discussion

1.6

13.5

345

2200

N06AA12

ATC

doxepin; systemic

1.9

13.5

187

986

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

13.5

263

1555

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.6

13.4

379

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

13.4

733

5508

R03BA02

ATC

budesonide; inhalant

1.5

13.4

562

4016

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

13.3

1411

11740

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

13.3

1909

16531

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

13.2

103

420

XQ801

NOMESCO Finland

Intracutantest

9.7

13.2

WX704

NOMESCO Finland

Intubation

1.7

13.2

255

1503

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

13.1

154

760

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

13.1

329

2089

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

13.1

233

1336

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

13.0

119

525

L13.9

ICD-10 Finland

Bullous disorder, unspecified

7.1

13.0

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.5

13.0

101

411

L04AA13

ATC

leflunomide; oral

2.6

12.8

364

P15

ICPC

Chronic alcohol abuse

2.4

12.8

106

446

A10BH01

ATC

sitagliptin; oral

1.6

12.8

319

2022

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

12.8

364

2388

N05AA02

ATC

levomepromazine; systemic

2.1

12.8

147

721

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

12.6

407

2746

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

12.6

142

690

N03AG01

ATC

valproic acid; systemic, rectal

1.8

12.6

203

1126

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.6

267

1620

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

12.5

271

1655

A03

ICPC

Fever

1.5

12.4

509

3616

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

12.4

106

453

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

12.3

312

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.3

491

3468

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

12.3

169

886

L01

ICD-10 Finland

Impetigo

3.6

12.3

151

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

12.2

1344

11212

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

12.2

307

1949

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

12.2

291

1824

J30.3

ICD-10 Finland

Other allergic rhinitis

2.3

12.2

110

483

WX110

NOMESCO Finland

Local anesthesy

1.3

12.2

2577

23293

J46

ICD-10 Finland

Status asthmaticus

2.5

12.1

377

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

12.1

126

592

B35.1

ICD-10 Finland

Tinea unguium

1.9

12.1

180

975

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

12.1

217

1249

C01CA24

ATC

epinephrine; parenteral

1.9

12.1

178

961

L14

ICPC

Leg/thigh symptom/complaint

1.7

12.1

238

1412

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.0

1284

10663

L23

ICD-10 Finland

Allergic contact dermatitis

7.2

12.0

L50.8

ICD-10 Finland

Other urticaria

3.2

11.9

192

S07

ICPC

Rash generalized

6.4

11.8

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

11.8

537

3894

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

11.8

643

4822

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

11.7

175

949

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

11.7

370

2486

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

11.7

105

462

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

11.7

614

4574

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

11.6

293

N07BB01

ATC

disulfiram; oral

1.9

11.6

164

871

H02AB09

ATC

hydrocortisone; systemic

2.6

11.6

324

N05BA04

ATC

oxazepam; oral

1.3

11.6

803

6258

B07.9

ICD-10 Finland

Verruca simplex

2.2

11.6

115

530

P17

ICPC

Tobacco abuse

3.3

11.6

180

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

11.6

257

1577

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.6

230

1367

C09CA01

ATC

losartan; oral

1.3

11.6

789

6136

B01AA03

ATC

warfarin; systemic

1.4

11.6

650

4897

M25.5

ICD-10 Finland

Pain in joint

1.3

11.6

935

7463

N05CD07

ATC

temazepam; oral

1.5

11.5

401

2754

1653

NOMESCO Finland

+∞

11.5

R06AX26

ATC

fexofenadine; oral

1.8

11.4

208

1205

N06AX16

ATC

venlafaxine; oral

1.5

11.4

438

3069

R51.80

ICD-10 Finland

Headache

1.5

11.4

457

3233

NHQ40

NOMESCO Finland

Amputation of toe

2.9

11.4

226

N06AB04

ATC

citalopram; systemic

1.4

11.4

694

5300

L71.9

ICD-10 Finland

Rosacea, unspecified

2.6

11.3

302

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.4

11.3

L40.8

ICD-10 Finland

Other psoriasis

4.3

11.2

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

11.2

180

1004

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.0

11.1

108

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

11.1

187

1056

R52.2

ICD-10 Finland

Other chronic pain

2.2

11.1

108

493

J45

ICD-10 Finland

Asthma

1.6

11.0

301

1954

SPAT1216

SPAT

Assessment of functional ability

1.4

11.0

470

3365

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.1

11.0

193

XQ845

NOMESCO Finland

Dermatoscopy

3.4

11.0

150

L16

ICPC

Ankle symptom/complaint

1.6

10.9

312

2045

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

10.9

1977

17447

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

10.9

902

7213

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

10.9

384

2642

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

10.9

244

1505

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.8

728

5643

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

10.8

137

700

L85.89

ICD-10 Finland

Other specified epidermal thickening

11.9

10.8

WX720

NOMESCO Finland

Own respiration

2.0

10.8

135

687

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

10.8

717

5553

XQ899

NOMESCO Finland

Other assessment of skin

8.8

10.7

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.9

10.7

225

K90.0

ICD-10 Finland

Coeliac disease

2.3

10.7

416

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.7

327

2184

B35.4

ICD-10 Finland

Tinea corporis

3.9

10.6

108

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

10.6

417

2935

J01FA10

ATC

azithromycin; systemic

1.2

10.6

2046

18162

P01BA02

ATC

hydroxychloroquine; oral

1.6

10.6

260

1641

A01

ICPC

Pain general/multiple sites

1.7

10.6

239

1477

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

10.6

149

791

EBA00

NOMESCO Finland

Extraction of tooth

1.3

10.6

1138

9430

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.0

10.6

N05AH03

ATC

olanzapine; systemic

1.7

10.5

194

1130

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

10.5

157

855

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

10.5

888

7126

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.0

10.5

100

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

10.4

181

1034

L08

ICPC

Shoulder symptom/complaint

1.4

10.4

600

4532

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.9

10.4

150

802

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

110.3

10.4

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.4

10.4

351

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

10.4

162

895

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

10.4

2032

18054

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

10.4

442

X58

ICD-10 Finland

Exposure to other specified factors

1.4

10.3

439

3141

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

8.2

10.3

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

10.3

2590

23644

1200

NOMESCO Finland

18.8

10.2

A10BK03

ATC

empagliflozin; oral

1.7

10.2

232

1433

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.2

894

7201

N05AF03

ATC

chlorprothixene; systemic

2.3

10.2

418

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

10.2

275

1780

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.9

10.2

209

L70.0

ICD-10 Finland

Acne vulgaris

2.6

10.2

293

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

10.2

735

5754

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

10.2

198

1172

N05BA01

ATC

diazepam; systemic, rectal

1.4

10.2

425

3032

S06.0

ICD-10 Finland

Concussion

1.5

10.2

321

2155

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

10.1

350

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.1

686

5323

R03AC12

ATC

salmeterol; inhalant

1.9

10.1

138

727

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.0

10.1

197

A06AD11

ATC

lactulose; oral

1.4

10.0

441

3174

J04AB02

ATC

rifampicin; systemic

3.1

9.9

174

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.9

1428

12240

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

9.9

315

N06AB03

ATC

fluoxetine; oral

1.5

9.9

399

2827

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.6

9.9

262

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

9.8

100

468

M10.9

ICD-10 Finland

Gout, unspecified

1.7

9.8

210

1277

N18.0

ICD-10 Finland

End-stage renal disease

3.3

9.8

143

J01CR50

ATC

combinations of penicillins; systemic

10.6

9.8

Z01.2

ICD-10 Finland

Dental examination

1.2

9.8

1388

11876

Z37.0

ICD-10 Finland

Single live birth

0.5

9.7

1391

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

9.7

320

D06BX01

ATC

metronidazole; topical

1.5

9.7

316

2140

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.2

9.7

431

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

9.6

1792

15786

A07AA02

ATC

nystatin; oral

1.7

9.6

191

1136

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

9.6

184

1086

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.5

1301

11069

I50.1

ICD-10 Finland

Left ventricular failure

1.9

9.5

145

795

K08.3

ICD-10 Finland

Retained dental root

1.6

9.5

233

1473

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.0

9.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

9.4

444

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.4

9.4

313

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.4

230

1451

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

9.4

341

2364

D11AH05

ATC

dupilumab; topical

+∞

9.4

WQ022

NOMESCO Finland

+∞

9.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.3

9.4

344

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

9.3

345

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

9.3

101

486

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

9.3

296

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

9.3

259

1689

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

9.3

239

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

6.9

9.3

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.7

9.3

223

D69.0

ICD-10 Finland

Allergic purpura

4.9

9.3

Z72.0

ICD-10 Finland

Tobacco use

2.2

9.3

411

SPAT1059

SPAT

Spirometry at the office

1.7

9.2

177

1042

H70

ICPC

Otitis externa

2.5

9.2

291

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

9.2

247

1595

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.2

561

4276

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

9.2

341

2377

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

9.1

293

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.5

9.1

302

2050

C10AC01

ATC

colestyramine; oral

2.3

9.1

364

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.2

9.1

146

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

9.1

119

618

L56.4

ICD-10 Finland

Polymorphous light eruption

8.3

9.0

L30.2

ICD-10 Finland

Cutaneous autosensitization

36.8

9.0

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

8.9

110

559

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

8.9

354

R95

ICPC

Chron obstructive pulmonary disease

2.2

8.9

419

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

8.9

1138

9598

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.1

8.9

149

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

8.9

124

662

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

7.9

8.8

SPAT1097

SPAT

Recording of ECG

1.4

8.8

482

3608

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

8.8

185

1124

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

8.6

8.8

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

8.8

121

642

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

8.8

711

5655

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

8.8

382

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.9

8.7

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.7

140

782

C09AA05

ATC

ramipril; oral

1.3

8.7

807

6536

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.4

8.7

282

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

8.7

105

527

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.7

747

5990

395

Kela drug reimbursment

Dupilumab

50.1

8.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

8.6

147

838

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

8.6

117

615

C02AC05

ATC

moxonidine; oral

1.8

8.6

139

780

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

8.6

309

N05AH02

ATC

clozapine; systemic

2.4

8.5

298

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

8.5

227

1465

S17

ICPC

Abrasion/scratch/blister

2.3

8.5

311

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

8.5

902

7432

49300

ICD-8 Finland

Asthma, bronchiale

2.3

8.5

331

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

27.6

8.5

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

8.5

170

1019

L98.1

ICD-10 Finland

Factitial dermatitis

20.0

8.5

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.9

8.4

170

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

8.4

198

1238

L12

ICPC

Hand/finger symptom/complaint

1.4

8.4

432

3196

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

8.4

103

520

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.6

8.4

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

5.6

8.4

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.4

261

1748

ZXA10

NOMESCO Finland

Bilateral

1.3

8.4

578

4492

A12AA04

ATC

calcium carbonate; oral

2.7

8.4

208

WXQ20

NOMESCO Finland

UVA broad spectrum light therapy

+∞

8.3

A10BJ06

ATC

semaglutide; parenteral

2.0

8.3

100

502

SPAT1285

SPAT

Provision of consultation response

1.7

8.3

170

1024

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

8.3

100

504

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

8.2

283

P16

ICPC

Acute alcohol abuse

2.6

8.2

228

K50.8

ICD-10 Finland

Other Crohn disease

2.7

8.2

204

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

8.2

699

5595

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

8.2

653

5177

SFA00

NOMESCO Finland

Small filling

1.4

8.2

409

3012

S91

ICPC

Psoriasis

3.6

8.2

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.2

929

7712

H01

ICPC

Ear pain/earache

1.5

8.2

312

2184

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

8.2

276

1881

E000005

ATC

14.5

8.2

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

8.2

257

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

8.2

110

579

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

8.1

490

3727

A12BA01

ATC

potassium chloride; oral

1.8

8.1

122

669

Z00.0

ICD-10 Finland

General medical examination

1.3

8.1

580

4527

SPAT1101

SPAT

Orthostatic test

1.8

8.1

125

688

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.6

8.1

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.3

8.1

115

K28

ICPC

Limited function/disability (K)

2.3

8.1

307

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.7

8.0

201

127

Kela drug reimbursment

Transplant complication

2.7

8.0

187

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.0

587

4598

R06.2

ICD-10 Finland

Wheezing

1.8

8.0

130

730

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

8.0

283

QDB10

SPAT

4.1

7.9

A02BC05

ATC

esomeprazole; systemic

1.2

7.9

1355

11767

A05

ICPC

Feeling ill

1.7

7.9

171

1046

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

7.9

222

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.8

7.9

183

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

7.9

184

1151

L43.8

ICD-10 Finland

Other lichen planus

2.5

7.9

233

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

7.8

111

593

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.2

7.8

319

S22.3

ICD-10 Finland

Fracture of rib

1.6

7.8

201

1290

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.4

7.8

253

B35.2

ICD-10 Finland

Tinea manuum

8.4

7.8

C07AB02

ATC

metoprolol; systemic

1.3

7.8

632

5025

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

7.8

113

613

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.0

7.8

502

J05AB01

ATC

aciclovir; systemic

1.3

7.8

634

5044

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.9

7.8

RS340

NOMESCO Finland

6.9

7.8

R05

ICD-10 Finland

Cough

1.3

7.8

596

4699

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.6

7.7

173

1069

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.7

716

5794

R03AC13

ATC

formoterol; inhalant

1.7

7.7

147

867

AN1

Coronary angiography

1.4

7.7

376

2762

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.7

7.7

181

K85

ICD-10 Finland

Acute pancreatitis

2.4

7.7

257

SPAT1139

SPAT

Nutrition survey

1.9

7.6

100

523

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.9

7.6

106

567

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.6

196

1259

WX213

NOMESCO Finland

Lower leg blockade

3.4

7.6

100

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

25.0

7.6

T82

ICPC

Obesity

1.9

7.6

105

560

S01GX02

ATC

levocabastine; ophthalmic

1.6

7.6

171

1060

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

7.6

274

1900

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.5

844

6986

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

7.5

1066

9070

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

7.5

140

824

C08CA02

ATC

felodipine; oral

1.5

7.5

279

1948

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

7.5

283

1981

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.2

7.5

112

J01CF02

ATC

cloxacillin; systemic

2.2

7.5

350

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.5

305

2165

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

7.5

194

1248

SBA00

NOMESCO Finland

Microbiological examinations

2.1

7.4

373

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

7.4

110

600

A07EC02

ATC

mesalazine; oral, rectal

1.6

7.4

162

997

R06AX18

ATC

acrivastine; oral

2.0

7.4

422

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.7

7.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

7.4

204

L40.2

ICD-10 Finland

Acrodermatitis continua

80.2

7.4

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

80.2

7.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

7.4

332

2400

A28

ICPC

Limited function/disability NOS

1.4

7.4

405

3030

R03AC03

ATC

terbutaline; inhalant

1.4

7.4

410

3075

C03AA03

ATC

hydrochlorothiazide; oral

1.5

7.4

286

2012

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

3.4

7.4

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

7.4

204

1333

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

7.4

137

804

SPAT1283

SPAT

Restricted health certificate

1.3

7.4

529

4132

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.5

7.4

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.5

7.3

1141

TK800

NOMESCO Finland

Hemodialysis

2.2

7.3

322

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

7.3

523

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.7

7.3

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

7.3

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

7.3

303

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.3

373

2760

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

7.3

279

1956

J01CA04

ATC

amoxicillin; systemic

1.2

7.3

3063

28861

N05AD01

ATC

haloperidol; systemic

2.0

7.3

487

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.3

477

3675

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

7.2

253

1740

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

7.2

163

1011

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

7.2

448

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

7.2

156

955

C08CA13

ATC

lercanidipine; oral

1.4

7.2

389

2906

L71.8

ICD-10 Finland

Other rosacea

2.7

7.2

161

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.2

987

8364

UKC02

NOMESCO Finland

Cystoscopy

1.3

7.1

503

3919

L25.8

ICD-10 Finland

Unspecified contact dermatitis due to other agents

30.0

7.1

L04AB01

ATC

etanercept; parenteral

2.6

7.1

196

SPAT1252

SPAT

Overall medication plan or its review

1.5

7.1

203

1337

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

7.1

222

Q82.88

ICD-10 Finland

Other specified congenital malformations of skin

20.0

7.1

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

7.1

490

3800

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.4

7.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

7.1

176

1118

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.2

7.1

111

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

7.1

423

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

7.0

174

LCA00

NOMESCO Finland

Biopsy of uterus or uterine ligaments

10.0

7.0

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.1

7.0

112

N05CF02

ATC

zolpidem; oral

1.3

7.0

533

4197

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.0

7.0

452

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.0

7.0

129

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

7.0

244

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

7.0

488

3793

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.7

7.0

167

L28

ICPC

Limited function/disability (L)

1.3

7.0

451

3467

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

7.0

275

1940

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.0

809

6723

K07

ICPC

Swollen ankles/oedema

1.8

7.0

119

682

J01FA09

ATC

clarithromycin; systemic

1.2

6.9

1026

8756

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

6.9

128

751

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

6.9

289

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.9

556

4410

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

6.9

117

669

P03

ICPC

Feeling depressed

1.5

6.9

249

1728

HAHOM

NOMESCO Finland

2.9

6.9

140

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

6.9

312

WQ066

NOMESCO Finland

13.8

6.9

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

6.9

129

761

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

6.9

319

2322

SPAT1234

SPAT

Support of social functional capacity

1.7

6.8

139

838

K70.1

ICD-10 Finland

Alcoholic hepatitis

3.7

6.8

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.8

6.8

-50

ICPC

Medication/prescr/renewal

1.7

6.8

132

784

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.3

6.8

241

S08

ICPC

Skin colour change

1.7

6.8

146

896

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.8

6.8

142

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

6.8

190

L40.4

ICD-10 Finland

Guttate psoriasis

5.0

6.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

6.8

504

3958

N05AB03

ATC

perphenazine; systemic, rectal

1.8

6.7

104

576

NHG20

NOMESCO Finland

Fusion of talocrural joint

3.8

6.7

NGW99

NOMESCO Finland

Other reoperation in surgery of knee or lower leg

16.7

6.7

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

16.7

6.7

A10BB12

ATC

glimepiride; oral

1.5

6.7

212

1430

P01

ICPC

Feeling anxious/nervous/tense

1.4

6.7

272

1932

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

6.7

113

643

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

6.7

143

878

A11CC03

ATC

alfacalcidol; systemic

2.1

6.7

348

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

6.7

138

N03AE01

ATC

clonazepam; systemic

1.6

6.7

173

1112

Z49.2

ICD-10 Finland

Other dialysis

3.6

6.7

D06BB04

ATC

podophyllotoxin; topical

1.6

6.6

144

886

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

6.6

179

1164

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

6.6

105

587

N03AX09

ATC

lamotrigine; oral

1.7

6.6

130

775

WX400

NOMESCO Finland

Inhalation anesthesy

1.7

6.6

134

810

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.1

6.6

316

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

6.6

176

1142

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.6

337

2494

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

6.6

163

1036

D11

ICPC

Diarrhoea

1.4

6.6

314

2295

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.6

733

6058

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.8

6.6

112

641

P29

ICPC

Psychological sympt/compl other

1.6

6.6

153

957

L15

ICPC

Knee symptom/complaint

1.3

6.6

622

5042

M03BX02

ATC

tizanidine; oral

1.2

6.6

2171

19931

H3603, E103

ICD-10 Finland

2.9

6.5

134

C84.0

ICD-10 Finland

Mycosis fungoides

10.0

6.5

R33

ICD-10 Finland

Retention of urine

1.5

6.5

234

1622

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

6.5

151

947

SPAT1210

SPAT

Application of cast or individual aid

1.7

6.5

119

699

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.8

6.5

135

D07XB01

ATC

flumetasone, combinations; topical

3.2

6.5

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

6.5

454

R18

ICD-10 Finland

Ascites

2.2

6.5

268

A10BH05

ATC

linagliptin; oral

1.7

6.5

132

800

R06.5

ICD-10 Finland

Mouth breathing

1.4

6.4

271

1939

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.6

6.4

140

861

T89

ICPC

Diabetes insulin dependent

1.7

6.4

118

693

E66.0

ICD-10 Finland

Obesity due to excess calories

2.9

6.4

129

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

6.4

129

K85

ICPC

Elevated blood pressure

1.3

6.4

428

3305

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.8

6.4

515

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

6.4

291

2112

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

6.4

184

1216

K92.0

ICD-10 Finland

Haematemesis

2.0

6.4

407

PE1AT

NOMESCO Finland

Femoral artery PTA

2.6

6.4

161

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

6.3

179

1179

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

6.3

146

915

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.4

6.3

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.5

6.3

179

-34

ICPC

Blood test

1.8

6.3

510

L04AC10

ATC

secukinumab; parenteral

5.2

6.3

Z08

ICPC

Social welfare problem

2.7

6.3

145

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

6.3

122

730

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.5

6.3

L03.3

ICD-10 Finland

Cellulitis of trunk

3.5

6.3

A02BA02

ATC

ranitidine; systemic

1.3

6.3

605

4914

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

6.3

199

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

6.3

433

3365

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.2

6.2

279

S82.3

ICD-10 Finland

Fracture of lower end of tibia

2.2

6.2

279

F91.2

ICD-10 Finland

Socialized conduct disorder

+∞

6.2

D82

ICPC

Teeth/gum disease

1.2

6.2

1122

9752

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

6.2

162

1045

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.1

6.2

318

S91.0

ICD-10 Finland

Open wound of ankle

3.0

6.2

112

T74.1

ICD-10 Finland

Physical abuse

2.2

6.2

252

S19

ICPC

Skin injury other

1.7

6.2

114

673

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.6

6.2

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

6.1

310

2290

T78.3

ICD-10 Finland

Angioneurotic oedema

2.5

6.1

184

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.5

6.1

166

K51.5

ICD-10 Finland

Left sided colitis

1.9

6.1

427

R01AD09

ATC

mometasone; nasal

1.2

6.1

1487

13276

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.0

6.1

372

S16

ICPC

Bruise/contusion

1.9

6.1

456

H29

ICPC

Ear symptom/complaint other

1.4

6.1

292

2137

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

6.1

1195

10468

RJ411

NOMESCO Finland

3.8

6.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

6.1

180

1197

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

6.0

168

1104

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.0

6.0

366

C10AA01

ATC

simvastatin; oral

1.2

6.0

1425

12686

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

175

110

16.47

206.23

1.5

1.4

u/ml

23.4

22.7

0.05

(40768443) Skin Pathology biopsy report

504

1231

4.45

188.69

1.4

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

147

17.39

178.41

1.2

1.4

titre

51.1

46.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

150

16.61

177.88

1.2

1.4

titre

300.9

213.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1002

4269

2.70

152.37

2.2

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

611

2007

3.34

147.93

1.4

1.3

u/ml

814.1

150.6

7.59

574

1843

(3000494) Fungus identified in Specimen by Culture

886

4250

2.33

100.58

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1452

8459

2.02

100.03

6.4

4.2

—

(3001604) Monocytes [#/volume] in Blood

2651

19078

1.86

94.21

7.8

5.6

e9/l

0.6

13.26

2452

16393

(3006315) Basophils [#/volume] in Blood

2659

19160

1.86

94.04

7.8

5.6

e9/l

0.0

10.45

2464

16475

(3013115) Eosinophils [#/volume] in Blood

2721

19831

1.84

91.89

8.1

5.8

e9/l

0.2

21.59

2530

17347

(3019198) Lymphocytes [#/volume] in Blood

2686

19673

1.82

87.43

7.9

5.7

e9/l

1.9

0.00

2504

17257

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1837

11995

1.85

87.29

3.1

2.5

u/l

57.8

58.2

0.09

1704

11073

(3013650) Neutrophils [#/volume] in Blood by Automated count

2890

22197

1.74

74.45

10.8

8.9

e9/l

4.3

4.1

6.83

2696

19310

(3024561) Albumin [Mass/volume] in Serum or Plasma

2268

16476

1.71

69.85

5.9

4.8

g/l

34.7

35.5

8.55

2113

15312

(3023368) Bacteria identified in Blood by Culture

1567

10360

1.76

67.26

5.3

4.2

—

(42870588) Differential panel, method unspecified - Blood

1865

12983

1.71

66.21

7.3

5.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2629

20066

1.67

65.58

6.3

6.2

umol/l

11.4

11.6

0.39

2489

19045

(3029937) Albumin [Presence] in Urine by Test strip

1539

10253

1.73

63.52

5.1

3.8

estimate

0.0

0.34

603

3436

(3019069) Monocytes/100 leukocytes in Blood

2409

18104

1.65

62.72

8.4

6.1

8.9

8.6

2.83

2310

16941

(3006504) Eosinophils/100 leukocytes in Blood

2395

17999

1.65

62.14

8.0

5.8

3.2

2.8

11.72

2285

16748

(3042936) Bacteria identified in Isolate by Culture

927

5363

1.90

60.87

2.5

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2025

14680

1.65

59.83

5.0

3.6

—

(3022096) Basophils/100 leukocytes in Blood

2326

17467

1.64

59.63

8.1

5.9

0.7

0.99

2232

16275

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3566

29926

1.72

58.17

9.0

7.4

u/l

80.6

77.9

1.79

3409

28194

(3002030) Lymphocytes/100 leukocytes in Blood

2439

18635

1.62

57.49

8.1

5.9

26.6

27.9

7.61

2329

17336

(3013707) Erythrocyte sedimentation rate by Westergren method

3444

28696

1.69

57.01

5.3

3.9

mm/h

14.4

11.8

16.26

3184

26581

(3032080) INR in Blood by Coagulation assay

2117

15654

1.62

56.86

11.8

9.2

inr

1.2

1.3

1.20

773

4514

(3019060) Gas panel - Arterial blood

519

2513

2.19

55.48

5.5

4.7

—

(3018010) Neutrophils/100 leukocytes in Blood

2384

18353

1.59

52.66

7.8

5.7

57.8

57.3

1.18

2281

17147

(3017181) Myelocytes/100 leukocytes in Blood

611

3220

2.03

52.08

4.7

4.0

0.8

0.9

0.85

173

883

(3013826) Glucose [Moles/volume] in Serum or Plasma

2833

22901

1.57

49.08

6.0

4.6

mmol/l

6.8

6.7

1.63

2678

21398

(3002179) Metamyelocytes/100 leukocytes in Blood

561

2929

2.03

48.92

4.5

3.8

0.6

0.7

0.26

126

642

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

7.59

48.76

1.6

1.5

ug/l

9.9

8.3

1.46

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2426

19024

1.55

47.49

8.4

6.6

mmol/l

1.2

4.10

1959

16105

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1213

8090

1.67

47.25

1.4

1.2

u/ml

1.4

1.9

1.31

376

2133

(3037522) Nuclear Ab [Titer] in Serum

818

4891

1.81

47.17

1.4

1.3

titre

432.5

540.7

1.34

161

964

(3035350) Ketones [Presence] in Urine by Test strip

2408

18925

1.54

46.14

4.7

3.4

estimate

0.0

0.80

605

3492

(3021440) Promyelocytes/100 leukocytes in Blood

571

3062

1.98

46.03

4.8

4.0

0.1

0.47

156

823

(3021601) Nitrite [Presence] in Urine by Test strip

2406

18941

1.53

45.50

6.0

4.7

estimate

0.0

0.28

624

3580

(3008152) Bicarbonate [Moles/volume] in Arterial blood

476

2407

2.08

45.12

8.2

6.7

mmol/l

24.7

24.5

0.50

445

2243

(3009261) Glucose [Presence] in Urine by Test strip

2427

19178

1.53

44.86

4.7

3.5

estimate

0.0

1.72

582

3462

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

688

3959

1.86

44.75

4.6

3.3

—

(3025159) Blasts/100 leukocytes in Blood

544

2905

1.98

44.31

4.7

4.1

0.7

0.1

0.43

129

689

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1379

9629

1.60

44.13

2.5

2.2

mg/l

3.1

2.9

1.56

1204

8249

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1607

11648

1.57

43.72

2.4

2.1

u/l

228.4

231.4

0.03

1491

10945

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1927

14543

1.54

43.70

4.5

3.5

ng/l

36.6

85.5

0.88

1366

9856

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1197

8165

1.62

41.82

1.8

1.7

pmol/l

18999416.0

38018652.2

0.83

979

6802

(40761536) Microorganisms panel - Urine sediment

586

3314

1.87

39.99

4.9

3.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

366

1781

2.14

38.20

4.3

3.4

mmol/l

25.2

0.08

359

1719

(3037467) Urinalysis macro (dipstick) panel - Urine

3155

26870

1.50

37.21

5.2

4.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3436

29804

1.52

36.91

4.4

3.9

pmol/l

14.9

14.8

1.49

3128

27162

(3003458) Phosphate [Moles/volume] in Serum or Plasma

786

4956

1.70

36.80

7.1

5.9

mmol/l

1.1

1.0

1.55

730

4614

(3003396) Base excess in Arterial blood by calculation

713

4419

1.72

35.46

7.5

7.2

mmol/l

1.3

1.1

1.14

545

3427

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

929

6169

1.63

35.43

2.0

1.8

—

(3016502) Oxygen saturation in Arterial blood

654

3976

1.75

34.80

7.7

7.5

95.8

95.6

0.38

619

3827

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

544

3136

1.83

34.67

4.6

3.7

mmol/l

1.2

0.26

477

2744

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2158

17223

1.45

34.46

7.4

5.9

mmol/l

1.2

2.71

1955

15603

(3018418) pH of Serum or Plasma

1504

11195

1.50

34.24

4.6

4.0

7.4

0.25

380

2149

(3012095) Magnesium [Moles/volume] in Serum or Plasma

935

6277

1.61

33.93

3.7

3.3

mmol/l

0.8

4.72

876

5874

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

709

4437

1.70

33.91

7.5

7.2

kpa

5.1

0.38

668

4239

(3027801) Oxygen [Partial pressure] in Arterial blood

708

4436

1.70

33.70

7.5

7.1

kpa

11.2

12.4

11.15

665

4235

(3002173) Hemoglobin [Mass/volume] in Arterial blood

608

3664

1.75

33.28

8.0

g/l

121.3

122.1

0.38

585

3528

(3020891) Body temperature

305

1470

2.15

32.55

6.0

4.6

—

(3026008) Bacteria identified in Urine by Culture

1495

11219

1.48

32.27

3.6

3.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1396

10350

1.49

31.95

4.3

3.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1001

6925

1.56

31.67

2.0

1.7

nmol/l

1257.1

1159.8

2.58

760

5241

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

156

562

2.83

31.37

1.2

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1577

12025

1.46

31.10

4.5

4.0

mg/mmol

13.6

8.9

2.63

1057

7709

(3015171) Extractable nuclear Ab [Units/volume] in Serum

278

1321

2.17

30.74

1.3

1.2

u/ml

0.2

0.8

2.45

121

(3004119) Hemoglobin [Mass/volume] in Venous blood

418

2306

1.89

30.49

4.7

3.2

g/l

125.2

129.7

3.75

410

2241

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

466

2663

1.83

30.40

1.9

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

885

6023

1.57

29.90

3.0

2.5

umol/l

12.3

13.2

3.02

823

5603

(3036481) Cortisol [Moles/volume] in Serum or Plasma

558

3395

1.73

29.33

2.3

2.1

nmol/l

365.2

376.3

0.57

515

3112

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1663

12928

1.44

29.11

3.8

3.2

u/l

36.4

35.5

0.11

1549

12277

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

659

4210

1.65

28.82

1.9

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1010

7134

1.52

28.72

1.5

g/l

2.8

2.5

4.42

658

4388

(3009445) Proteinase 3 Ab [Units/volume] in Serum

301

1515

2.05

28.61

1.4

1.5

u/ml

3.0

18.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

337

3.29

28.59

1.7

1.4

25.2

32.2

1.14

199

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1419

10740

1.45

28.57

3.5

3.0

ng/l

1907.3

1425.9

1.96

1214

9176

(3004789) Transferrin [Mass/volume] in Serum or Plasma

821

5565

1.57

28.05

3.0

2.4

g/l

2.3

0.01

757

5168

(3021447) Carbon dioxide [Partial pressure] in Venous blood

566

3499

1.70

28.01

5.2

3.8

kpa

5.9

5.8

0.82

551

3389

(3021589) Normoblasts [#/volume] in Blood

2111

17200

1.40

27.97

13.5

9.2

e9/l

0.0

0.42

1875

14033

(3020630) Protein [Mass/volume] in Serum or Plasma

508

3051

1.74

27.91

2.2

2.7

g/l

66.7

66.3

0.41

467

2780

(3012516) Albumin [Mass/volume] in Urine

1490

11436

1.44

27.64

3.5

3.2

mg/l

595.8

270.0

1.53

999

7307

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

651

4198

1.64

27.34

1.9

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

238

1120

2.18

26.96

5.3

4.0

mmol/l

3.9

0.29

228

1043

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

667

4343

1.62

26.91

3.9

4.2

u/l

239.8

243.5

0.29

634

4113

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

310

1612

1.99

26.89

5.8

5.0

1.8

1.6

1.40

289

1506

(3009508) Creatinine [Moles/volume] in Urine

1574

12253

1.42

26.80

3.6

3.2

mmol/l

7.5

7.7

1.07

1314

10310

(3019150) Specific gravity of Urine by Refractometry

1133

8296

1.48

26.78

5.3

3.8

kg/l

1.0

1.34

181

1268

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

235

1104

2.19

26.73

2.2

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

269

1336

2.07

26.50

5.1

3.8

mmol/l

1.4

0.19

263

1315

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

561

3516

1.67

26.28

2.3

2.2

g/l

0.2

1.54

514

3277

(3007930) Methemoglobin/Hemoglobin.total in Blood

305

1591

1.98

26.22

5.9

5.0

0.9

0.40

285

1490

(3002032) Base excess in Venous blood by calculation

558

3497

1.67

26.14

5.2

3.8

mmol/l

2.1

2.0

0.14

456

2812

(3026493) Urate [Moles/volume] in Serum or Plasma

1347

10239

1.44

26.02

3.0

2.6

umol/l

3863.0

4645.5

0.29

1181

8905

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

292

1511

1.99

25.68

2.0

1.9

ug/l

1.5

2.7

1.24

264

1341

(3024354) Oxygen [Partial pressure] in Venous blood

473

2848

1.73

25.68

4.8

3.1

kpa

4.5

4.6

1.31

456

2749

(3023520) Reticulocytes [#/volume] in Blood

511

3147

1.70

25.54

2.4

2.5

e9/l

71.7

68.8

1.06

412

2386

(1616796) Gas panel - Central venous blood

195

870

2.29

25.14

4.7

3.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

761

5187

1.55

25.13

3.1

2.5

21.6

23.2

2.20

610

4442

(3047181) Lactate [Moles/volume] in Blood

250

1240

2.07

24.71

6.3

5.9

mmol/l

1.2

1.3

0.43

218

1084

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

214

1003

2.19

24.49

1.6

g/l

1.1

1.2

1.00

204

946

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1135

8449

1.45

24.26

2.0

1.7

mg/l

1.2

0.07

893

6466

(3020779) Urea [Moles/volume] in Serum or Plasma

537

3396

1.65

24.21

9.8

7.5

mmol/l

10.7

10.0

1.54

513

3225

(3031040) Bacteria [#/volume] in Urine by Automated count

2934

25588

1.37

23.99

5.1

4.2

e6/l

133.4

1373.2

3.30

368

(3004588) Protein electrophoresis panel - Serum or Plasma

417

2476

1.75

23.73

1.8

2.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

312

1697

1.90

23.68

4.0

2.6

0.7

0.6

2.67

302

1629

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

317

1739

1.88

23.43

4.0

2.7

1.4

1.2

1.45

317

1728

(40767503) Oxygen content in Capillary blood by calculation

183

824

2.27

23.10

3.2

2.4

16.4

16.2

0.23

103

412

(3014576) Chloride [Moles/volume] in Serum or Plasma

707

4832

1.54

22.90

8.1

6.9

mmol/l

103.7

104.5

3.93

691

4715

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

204

965

2.16

22.82

1.6

g/l

0.2

0.14

190

912

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

228

1132

2.06

22.48

1.7

1.6

iu/ml

5.9

8.1

0.11

248

(3021960) Folate [Moles/volume] in Serum or Plasma

1159

8770

1.42

22.37

1.6

1.5

nmol/l

18.8

20.5

3.69

1017

7505

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

119

448

2.70

22.09

1.6

1.5

58.6

57.6

0.07

275

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3907

35936

1.44

21.97

5.2

4.5

mu/l

1.9

2.2

1.66

3598

32979

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4234

39605

1.53

21.50

20.8

13.5

mg/l

23.6

24.0

0.29

3655

31208

(3027945) Reticulocytes/100 erythrocytes in Blood

628

4238

1.55

21.45

2.3

2.5

1.9

1.8

1.85

551

3761

(40760888) Immunoglobulin light chains.free panel - Serum

183

860

2.17

20.83

1.8

3.8

—

(40761535) Cells panel - Urine sediment

481

3074

1.63

20.67

4.3

3.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

5.53

20.52

1.1

u/ml

3.6

0.6

0.63

(3012501) Base excess in Blood by calculation

185

885

2.13

20.14

5.6

4.1

mmol/l

3.1

2.5

1.25

136

591

(3039000) Anion gap in Blood

184

881

2.13

19.99

7.2

6.7

mmol/l

11.1

11.2

0.08

164

788

(3018572) Chloride [Moles/volume] in Blood

184

882

2.13

19.93

7.2

6.7

mmol/l

104.5

105.4

1.50

164

789

(3019550) Sodium [Moles/volume] in Serum or Plasma

4314

40641

1.54

19.85

22.8

15.6

mmol/l

139.3

139.7

19.42

4233

39644

(3023183) Ammonium ion [Moles/volume] in Plasma

172

807

2.17

19.68

3.0

umol/l

32.5

35.8

0.96

140

688

(3015377) Calcium [Moles/volume] in Serum or Plasma

1580

12796

1.35

19.64

3.2

3.4

mmol/l

2.3

2.4

0.82

1388

11210

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

208

1054

2.02

19.42

2.1

1.8

—

(3048689) Calprotectin [Mass/mass] in Stool

645

4476

1.51

19.23

2.9

2.3

ug/g

160.7

136.2

0.78

514

3520

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1865

15528

1.33

19.03

2.7

2.2

nmol/l

74.3

76.9

3.62

1712

14014

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

861

6341

1.43

18.91

1.3

iu/ml

29.0

33.1

0.53

294

1966

(3023103) Potassium [Moles/volume] in Serum or Plasma

4320

40787

1.53

18.82

22.8

15.7

mmol/l

4.0

2.07

4236

39717

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

233

1243

1.92

18.75

2.6

2.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1978

16632

1.32

18.72

3.4

2.8

ug/l

142.6

131.5

0.72

1834

15427

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

226

1207

1.91

18.14

1.5

1.6

titre

983.1

375.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

171

3.54

17.98

1.5

1.4

3.1

3.2

0.01

(3000850) Epithelial cells [#/volume] in Urine

1062

8184

1.38

17.82

3.0

2.6

e6/l

5.0

5.3

0.38

954

7168

(3010421) pH of Blood

201

1041

1.97

17.66

5.5

4.0

7.4

0.49

184

872

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

672

4779

1.47

17.66

2.0

1.7

1.5

7.41

567

4215

(3005719) IgG [Mass/volume] in Serum or Plasma

434

2820

1.59

17.34

3.1

2.6

g/l

11.0

10.6

0.97

401

2563

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

108

4.20

17.16

3.6

2.8

mg/l

7.4

7.9

0.21

(3026389) Candida sp identified in Specimen by Organism specific culture

118

505

2.37

16.84

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

192

996

1.97

16.80

1.5

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2941

26305

1.30

16.76

4.0

3.0

u/l

58.7

48.1

6.10

2735

24528

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

236

1312

1.84

16.73

2.6

2.3

ug/l

541.8

690.8

0.30

225

1238

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

812

6042

1.41

16.64

1.3

1.2

u/ml

8.4

12.7

1.34

337

2341

(4010399)

403

2599

1.60

16.60

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

350

2180

1.65

16.60

1.7

1.5

—

(3026782) Osmolality of Urine

987

7601

1.37

16.46

3.5

2.7

mosm/kgh2o

530.2

552.3

2.41

864

6489

(3015235) Bicarbonate [Moles/volume] in Capillary blood

190

1000

1.94

15.96

2.9

3.5

mmol/l

24.8

24.9

0.02

171

863

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

375

2408

1.60

15.72

9.0

9.1

0.7

0.30

368

2392

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

743

2.08

15.71

5.2

5.7

iu/ml

431.2

2762.8

0.58

107

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

375

2416

1.60

15.50

8.9

9.0

1.5

1.3

2.95

366

2402

(3028026) IgM [Mass/volume] in Serum or Plasma

345

2185

1.62

15.30

1.8

1.9

g/l

1.3

0.10

316

1986

(3020961) Endomysium IgA Ab [Titer] in Serum

280

1683

1.70

15.20

1.2

1.1

titre

77.5

120.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

149

3.45

14.78

1.5

1.6

ug/l

7.0

10.4

0.94

128

(3021901) Oxygen saturation in Capillary blood

145

714

2.06

14.71

3.0

3.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1830

15585

1.28

14.57

2.1

1.9

pmol/l

94.0

95.2

0.51

1057

8188

(3009343) pH of Capillary blood

371

2434

1.57

14.18

3.6

3.7

7.4

0.27

288

(3017143) Hepatitis C virus Ab [Presence] in Serum

603

4370

1.43

14.17

1.8

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

481

3338

1.49

14.16

7.3

7.0

mmol/l

1.4

0.12

463

3209

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

375

2470

1.56

14.09

3.7

kpa

5.2

5.1

0.06

347

2291

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2133

18576

1.26

13.91

5.2

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3855

36103

1.33

13.78

7.0

5.6

mmol/mol

40.8

39.8

8.65

3584

33523

(3028626) Oxygen [Partial pressure] in Capillary blood

170

907

1.91

13.75

3.3

3.4

kpa

8.3

8.2

0.17

162

834

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

357

2343

1.57

13.63

3.6

mmol/l

1.6

1.8

0.22

267

1723

(3025941) Bacteria identified in Stool by Culture

327

2106

1.59

13.54

1.4

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

650

2.06

13.43

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

222

1296

1.75

13.40

2.3

2.2

u/l

4241.9

5141.8

0.18

513

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

461

3211

1.48

13.31

3.4

2.9

ng/l

214.3

197.1

0.25

420

2935

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

204

1165

1.78

13.29

1.8

3.6

mg/l

42.6

59.2

0.70

140

950

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

328

2127

1.58

13.19

9.8

9.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

6.59

13.18

1.0

u/ml

4.4

0.3

0.44

(3034860) Kappa light chains.free [Mass/volume] in Serum

203

1165

1.77

13.01

1.8

3.6

mg/l

69.9

58.0

0.55

140

952

(40761511) CBC panel - Blood by Automated count

4328

41356

1.42

12.93

19.8

12.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

6.39

12.81

1.1

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

189

1067

1.80

12.81

1.4

1.3

—

(3000991) Gas panel - Venous blood

451

3156

1.47

12.71

9.2

8.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

197

1129

1.78

12.69

1.8

3.5

ratio

3.9

2.4

0.44

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

149

3.24

12.69

1.7

umol/l

216.1

150.3

0.33

(3044889) 12 lead EKG panel

3025

27608

1.25

12.49

4.5

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

872

6843

1.33

12.49

1.9

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

132

669

2.00

12.43

3.6

3.0

—

(3042631) Mycobacterium sp identified in Specimen

108

509

2.15

12.35

2.1

2.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

782

6050

1.35

12.31

2.8

2.1

30.1

29.9

0.31

755

5882

(3013512) EKG study

1345

11224

1.27

12.09

4.3

3.8

—

(3004451) EKG impression Narrative

180

2.97

12.07

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

100

462

2.19

12.03

1.8

2.5

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

8.85

12.00

1.0

u/ml

0.5

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

106

505

2.12

11.81

1.3

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

465

3335

1.44

11.50

2.6

2.3

ug/l

6.1

7.8

1.09

413

2937

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

3.97

11.45

2.1

1.7

au/ml

22.5

187.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

399

2784

1.47

11.40

4.8

3.8

ng/l

103.2

91.0

1.35

329

2399

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

132

693

1.93

11.27

1.3

1.2

u/ml

1.3

6.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

622

4709

1.37

11.20

10.9

6.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

438

3122

1.44

11.19

2.8

2.6

ml/min/173m2

62.2

66.8

1.48

197

1229

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

266

1708

1.59

11.18

1.5

1.7

g/l

1.5

0.21

219

1483

(44813793)

228

2.65

11.12

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

841

6665

1.32

11.12

1.7

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

167

951

1.78

11.04

4.9

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

156

872

1.82

10.97

1.9

1.6

e6/l

13059.9

13141.1

0.01

127

638

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

232

3608

0.63

10.96

1.6

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

160

907

1.79

10.75

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

114

580

1.99

10.68

1.3

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

153

858

1.81

10.66

2.6

2.2

g/l

130.9

129.5

0.31

130

612

(3022217) INR in Platelet poor plasma by Coagulation assay

662

5101

1.34

10.60

26.7

24.3

inr

1.3

0.49

128

742

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

165

949

1.76

10.56

2.0

2.1

mg/l

10.6

10.9

0.12

152

874

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

110

3.38

10.52

2.3

2.0

mg/l

8.9

9.4

0.22

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

156

886

1.79

10.43

1.5

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.02

10.38

2.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

165

956

1.75

10.30

2.5

2.4

ug/min

148.6

102.4

0.42

597

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

7.16

10.13

1.0

u/ml

0.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

517

2.01

10.05

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

335

2.26

9.87

1.6

1.3

e6/l

20064.9

121660.4

1.93

232

(3043238) Trisomy 21 risk [Likelihood] in Fetus

737

0.24

9.79

1.4

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

6.84

9.73

1.0

u/ml

0.1

0.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

130

715

1.84

9.68

1.3

1.2

—

9.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

720

0.25

9.43

1.4

—

(3005033) Fetal Nuchal fold Thickness US

716

0.25

9.35

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

169

1018

1.68

9.21

3.8

3.3

mg/l

1.6

1.5

0.54

151

932

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

514

1.97

9.16

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

563

1.92

9.15

2.8

u/ml

527.1

1953.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

119

650

1.85

9.08

1.5

1.6

—

(3037756) Immunofixation for Serum or Plasma

131

739

1.79

9.01

1.3

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

2.81

8.99

1.2

1.1

miu/ml

1662.4

1452.2

0.50

154

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

719

5732

1.30

8.97

1.8

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

304

2.25

8.96

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

160

2.77

8.94

36.7

33.6

ug/l

7.3

7.5

0.31

147

(3030467) Casts [#/volume] in Urine by Automated count

1267

10804

1.23

8.93

3.6

3.1

e6/l

0.4

0.44

1031

8114

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

250

2.38

8.80

2.3

2.2

—

(3038515) Glucose [Moles/volume] in Venous blood

136

782

1.76

8.78

4.6

3.2

mmol/l

7.5

0.11

136

761

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1209

10275

1.24

8.77

1.8

1.6

mmol/l

1.4

0.24

959

8620

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3993

38128

1.26

8.70

5.1

4.4

mmol/l

6.0

5.9

5.17

3630

34844

(3004809) Band form neutrophils/100 leukocytes in Blood

112

612

1.85

8.56

3.5

3.3

0.8

1.5

2.58

459

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

105

562

1.89

8.56

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1373

11849

1.22

8.56

3.7

3.2

e6/l

48.4

93.9

2.05

1124

9100

(3011397) Hemoglobin [Presence] in Urine by Test strip

1058

8887

1.24

8.52

4.7

3.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

248

2.35

8.49

1.1

1.3

u/ml

5.3

0.5

0.99

111

(3000570) Elastase.pancreatic [Mass/mass] in Stool

173

1073

1.63

8.45

1.4

ug/g

277.3

277.8

0.01

102

609

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

869

0.35

8.40

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

868

0.35

8.38

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

867

0.35

8.36

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

333

2.15

8.35

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

864

0.35

8.30

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

173

2.62

8.25

1.1

1.0

u/ml

0.5

0.9

0.31

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

281

1955

1.46

8.19

2.5

2.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4369

42269

1.33

8.13

13.8

9.9

u/l

26.7

26.8

0.10

4251

40764

(3020123) Porphyrins [Interpretation] in Serum or Plasma

9.11

8.08

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

502

1.91

8.07

1.1

u/ml

3.1

1.8

0.24

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

234

1575

1.51

8.04

2.0

1.9

u/l

38.2

39.1

0.27

216

1393

(3000012) Reticulocyte production index

182

2.54

7.97

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

820

1.70

7.96

1.3

—

(3021788) Differential panel - Synovial fluid

116

656

1.79

7.96

1.7

1.5

—

(36660697) Celiac disease serology panel - Serum

392

2910

1.38

7.94

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

3488

32937

1.21

7.87

23.4

16.5

13.9

13.7

17.04

3427

32206

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

487

1.91

7.79

7.5

6.8

mg/l

11.8

0.02

450

(3024980) IgG subclass 4 [Mass/volume] in Serum

107

596

1.81

7.73

1.5

1.6

g/l

0.7

0.8

0.43

455

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

155

958

1.64

7.71

1.4

1.2

u/ml

30.3

37.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

267

2.22

7.61

2.4

2.2

13.3

14.3

0.21

117

(3022145) Colonoscopy Study observation

539

4226

1.31

7.57

1.4

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

154

2411

0.63

7.52

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

143

873

1.66

7.48

1.4

1.2

u/ml

10.2

6.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

403

1.98

7.47

1.8

2.2

umol/l

5.7

6.9

0.33

285

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

144

882

1.65

7.44

1.4

1.2

u/ml

3.4

6.0

0.91

148

(3028707) Methadone [Presence] in Urine by Screen method

104

583

1.80

7.38

3.6

2.7

—

(3004616) Nuclear Ab [Presence] in Serum

412

1.96

7.37

1.4

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

304

2.12

7.34

1.4

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

380

1.99

7.24

1.4

1.3

g/l

3.0

0.03

274

(4062490)

381

1.98

7.19

1.4

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

162

2.54

7.16

3.9

3.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

110

633

1.75

7.16

1.1

u/ml

1.7

1.1

0.25

211

(3041354) Potassium [Moles/volume] in Venous blood

473

1.88

7.15

3.1

2.3

mmol/l

4.1

0.46

466

(3035285) Chloride [Moles/volume] in Venous blood

473

1.88

7.15

3.1

2.3

mmol/l

106.5

105.5

1.02

466

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

942

0.43

7.08

1.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

820

6831

1.24

7.00

2.9

3.0

mmol/l

2.5

2.4

2.66

734

5971

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

892

7500

1.23

6.98

4.5

3.6

ng/l

320.4

564.2

0.95

686

5831

(40768797) Stomach Pathology biopsy report

648

5257

1.27

6.96

1.3

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.01

6.90

1.0

u/ml

0.8

0.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

380

1.96

6.90

1.4

1.3

g/l

0.5

0.4

0.88

271

(3027135) IgG subclass 1 [Mass/volume] in Serum

381

1.96

6.85

1.4

1.3

g/l

6.8

0.03

271

(3011412) CD3 cells [#/volume] in Blood

334

2.02

6.79

2.3

2.4

e9/l

0.9

1.1

1.70

210

(3033705) Calcium.ionized [Moles/volume] in Venous blood

461

1.86

6.74

3.2

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

125

1998

0.62

6.70

1.8

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.70

6.68

1.1

1.2

u/ml

0.0

—

(4198724)

151

2.53

6.58

1.8

—

(36304419) Bacteria [Presence] in Urine

1209

10534

1.20

6.52

3.5

3.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

152

2.51

6.50

26.4

24.9

ug/l

111.2

118.5

0.28

120

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

136

855

1.61

6.39

1.5

—

(21494755) Public health laboratory ask at order entry panel

281

3797

0.72

6.37

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

195

1330

1.49

6.35

3.2

u/ml

0.3

0.08

116

760

(3030981) Hyaline casts [#/volume] in Urine by Automated count

281

2056

1.39

6.26

2.8

e6/l

0.3

0.06

272

2003

(3048929) Epstein Barr virus Ab [Presence] in Serum

172

1148

1.52

6.23

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

132

833

1.60

6.12

1.6

1.5

—

(3018095) Leukocytes [#/volume] in Urine

1544

13799

1.17

6.12

4.1

3.6

e6/l

106.0

101.2

0.06

1205

9773

(3003888) Timothy IgE Ab [Units/volume] in Serum

552

1.74

6.04

1.1

u/ml

5.5

4.2

0.30

251

(3019897) Erythrocyte distribution width [Ratio] by Automated count

508

1.77

6.02

2.3

2.5

13.3

13.2

0.87

503

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

542

4380

1.27

6.00

2.7

2.8

umol/l

10.7

8.2

1.04

446

3830

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

546

4419

1.27

5.97

1.6

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

429

1.83

5.96

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

2.99

5.94

2.5

2.4

e6/l

87.4

162.9

1.32

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

151

993

1.54

5.87

1.1

u/ml

1.9

4.9

—

122

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

711

1.63

5.81

1.8

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

326

1.94

5.81

2.2

1.5

promille

1.2

1.3

0.28

249

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

131

2.53

5.77

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

352

2705

1.32

5.73

3.8

2.9

e9/l

4.2

4.1

0.23

283

2120

(3014133) Dog dander IgE Ab [Units/volume] in Serum

435

1.81

5.72

1.1

u/ml

4.9

2.0

0.82

135

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

103

2.73

5.68

1.3

1.4

36.4

30.9

0.31

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3891

37451

1.19

5.67

4.5

3.9

mmol/l

1.4

1.3

5.88

3542

34409

(21494890) Protein electrophoresis panel - 24 hour Urine

379

1.86

5.65

1.4

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

153

2.36

5.46

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

218

2.12

5.40

1.2

1.6

u/l

4.7

7.1

1.89

186

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

196

1385

1.43

5.37

1.6

1.7

—

(3003181) Sodium [Moles/volume] in Urine

101

619

1.65

5.32

1.4

mmol/l

61.9

64.1

0.20

498

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4038

39050

1.20

5.31

5.1

4.3

mmol/l

4.5

4.7

8.99

3709

36310

(3014599) Egg white IgE Ab [Units/volume] in Serum

174

2.25

5.31

1.0

u/ml

0.6

0.5

0.20

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.79

5.29

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4103

39762

1.20

5.15

5.4

4.8

mmol/l

2.7

2.8

6.29

3748

36757

(1001926) Buprenorphine [Presence] in Urine by Screen method

156

1067

1.48

5.09

2.8

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

699

8202

0.83

5.02

2.9

3.0

ug/l

0.8

0.04

462

5466

(3009466) Valproate [Moles/volume] in Serum or Plasma

545

1.66

4.99

5.2

umol/l

389.0

362.6

0.98

466

(3044941) Cell count panel - Synovial fluid

561

1.65

4.97

1.6

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

173

2.21

4.96

1.1

u/l

64.4

29.2

0.60

132

(3008295) Osmolality of Serum or Plasma

389

1.78

4.94

1.4

mosm/kgh2o

280.0

0.00

307

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

389

1.78

4.94

1.3

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

130

2.39

4.88

2.0

2.3

e6/l

709.9

598.8

0.17

(3017704) Immunofixation for Urine

201

2.10

4.85

1.3

1.4

—

(44790049)

429

1.74

4.82

1.6

1.5

—

(44790047)

429

1.74

4.82

1.6

1.5

—

(44806118)

429

1.74

4.82

1.6

1.5

—

(44790048)

429

1.74

4.82

1.6

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

169

2.20

4.80

1.1

—

(3016879) Cocaine [Presence] in Urine

179

1272

1.42

4.79

2.7

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4002

38765

1.18

4.70

4.8

4.3

mmol/l

1.4

5.20

3650

35855

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

246

1.96

4.62

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

152

1058

1.45

4.57

1.3

1.2

titre

121.4

117.1

0.03

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

173

2.15

4.55

1.1

u/l

127.4

89.4

0.61

135

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.98

4.55

1.4

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.56

4.54

1.3

1.6

g/l

14.3

12.6

0.33

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.01

4.51

2.1

3.5

—

(3034770) Mitochondria Ab [Titer] in Serum

151

1055

1.45

4.46

1.3

1.2

titre

805.0

1154.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

118

2.38

4.39

1.3

1.2

g/l

38.9

39.4

0.05

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.62

4.39

2.4

2.2

—

(3016750) Collection duration of Urine

237

1.95

4.38

2.3

2.1

min

471.4

490.0

0.71

176

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

488

1.65

4.36

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

217

1.99

4.35

1.3

1.6

—

(3011288) Drugs identified in Urine by Screen method

133

914

1.47

4.29

3.8

2.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

145

2.21

4.26

1.6

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

149

1048

1.44

4.26

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

219

1.97

4.24

2.2

2.6

e9/l

0.2

0.14

191

(3021879) Hepatitis B virus core Ab [Presence] in Serum

354

2840

1.27

4.21

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

180

1312

1.39

4.21

1.8

1.6

mu/l

353.1

295.7

0.72

165

1183

(3008401) Mugwort IgE Ab [Units/volume] in Serum

533

1.61

4.17

1.1

u/ml

0.9

0.8

0.06

189

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

214

1.97

4.15

1.3

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

128

2.27

4.12

1.1

—

(3004775) Volume in Urine collected for unspecified duration

322

1.78

4.11

2.4

2.2

679.7

629.6

0.36

213

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.76

4.08

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.51

4.04

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

2.31

4.00

2.4

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

461

1.64

4.00

1.3

1.5

—

(4034850)

171

1248

1.38

3.99

10.5

9.3

—

(3044007) Cell count panel - Peritoneal fluid

111

2.35

3.98

2.5

2.0

—

(3028300) Cannabinoids [Presence] in Urine

187

1386

1.36

3.97

2.6

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

304

1.79

3.95

1.2

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

304

1.79

3.95

1.2

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

304

1.79

3.95

1.2

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

356

1.72

3.95

1.1

1.2

u/l

66.0

58.8

0.13

238

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

356

1.72

3.95

1.3

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1413

1.36

3.95

1.8

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1413

1.36

3.95

1.8

2.4

g/l

4.1

3.8

1.85

114

1027

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

118

2.30

3.93

1.9

2.1

e6/l

1784.6

4553.6

0.78

(3000764) Benzodiazepines [Presence] in Urine

185

1371

1.36

3.93

2.6

2.0

—

(3027008) Opiates [Presence] in Urine

186

1380

1.36

3.92

2.6

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

859

0.57

3.92

2.0

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

108

726

1.50

3.92

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

1415

1.36

3.92

1.8

2.4

g/l

7.6

7.4

0.65

119

1077

(3040151) Glucose [Moles/volume] in Capillary blood

433

1.65

3.91

5.0

21.0

mmol/l

7.8

7.3

0.52

362

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.89

3.89

1.2

1.3

u/l

94.5

557.5

0.47

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

228

1.89

3.81

2.1

2.5

e6/l

488.4

486.8

0.01

192

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

1320

1.36

3.78

1.6

2.5

g/l

10.2

10.1

0.05

136

1132

(3014765) Yersinia sp identified in Stool by Organism specific culture

147

1057

1.40

3.76

1.3

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

196

1477

1.34

3.75

1.1

u/ml

0.9

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

134

2.17

3.72

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

230

1.88

3.72

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

148

2.10

3.68

2.8

2.2

nmol/l

126.2

153.7

0.98

129

(42529406) Shigella sp [Presence] in Stool by Culture

147

1063

1.39

3.65

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

2.12

3.64

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

129

2.18

3.63

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.54

3.62

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

104

707

1.48

3.61

1.5

1.2

u/ml

74.8

37.8

0.84

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

292

1.75

3.56

1.2

1.3

mmol/l

2.1

0.02

274

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.57

3.54

1.2

mmol/l

1.4

1.7

0.45

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

227

1.86

3.54

1.3

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

541

1.54

3.51

1.0

1.1

g/l

1.6

1.5

0.51

487

(3033799) Differential panel - Peritoneal fluid

118

2.21

3.50

2.7

2.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

10.01

3.49

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

401

1.63

3.47

1.1

u/ml

8.2

3.3

0.78

127

(3027944) Amphetamines [Presence] in Urine

180

1358

1.34

3.45

2.6

1.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

4504

44296

1.23

3.43

30.3

20.0

g/l

134.0

136.0

14.69

4449

43679

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

233

1825

1.29

3.42

6.2

4.1

mmol/l

23.9

24.2

0.67

195

1652

(3007461) Platelets [#/volume] in Blood

4500

44256

1.22

3.41

30.2

19.9

e9/l

256.7

249.2

10.68

4437

43140

(3014148) Varicella zoster virus Ab [Titer] in Serum

458

1.58

3.40

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

656

5724

1.17

3.34

1.5

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

456

0.46

3.33

1.7

1.6

—

(3024731) MCV [Entitic volume]

4501

44280

1.22

3.31

30.0

19.8

91.3

91.0

4.36

4448

43669

(3026361) Erythrocytes [#/volume] in Blood

4501

44283

1.22

3.29

30.1

19.9

e12/l

4.4

4.5

15.64

4425

43051

(3035941) MCH [Entitic mass]

4500

44276

1.22

3.26

30.0

19.8

30.4

30.3

1.14

4448

43662

(3010813) Leukocytes [#/volume] in Blood

4501

44292

1.22

3.23

30.2

19.9

e9/l

7.1

6.7

23.89

4424

43043

(3016038) Potassium [Moles/volume] in Urine

242

1.78

3.22

1.0

1.2

mmol/l

30.2

36.0

1.25

210

(40768446) Kidney Pathology biopsy report

143

2.03

3.20

1.8

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

483

1.54

3.15

1.5

1.4

e6/l

2384.5

2443.9

0.03

346

(3022313) Gas panel - Capillary blood

226

1784

1.28

3.14

4.0

3.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

193

1494

1.30

3.12

1.8

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.29

3.09

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

105

2.20

3.08

1.5

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

288

2346

1.24

3.08

3.0

3.4

pmol/l

4.3

4.5

3.33

253

2084

(3017509) Phencyclidine [Presence] in Urine

3.24

3.05

1.0

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

2.51

3.03

1.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.26

3.02

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

106

2.18

3.02

1.4

1.2

g/l

0.3

0.25

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

473

1.53

3.00

1.1

1.4

pmol/l

353.4

345.2

0.03

368

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

207

1628

1.28

2.98

2.0

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

687

1.44

2.97

3.2

3.0

nmol/l

0.8

0.22

520

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

547

1.49

2.97

1.4

1.3

mmol/l

7.0

7.3

0.50

414

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

150

1130

1.34

2.95

3.1

2.6

g/l

3.7

3.6

0.36

139

1071

(3013139) Helicobacter pylori Ag [Presence] in Stool

307

2530

1.23

2.95

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

549

1.48

2.92

1.4

1.3

nmol/l

0.2

0.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

101

716

1.42

2.89

1.5

1.2

u/ml

255.2

270.7

0.22

459

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

366

1.59

2.88

2.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.50

2.87

1.3

mmol/l

0.3

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

761

1.40

2.83

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.19

2.83

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

376

1.58

2.82

1.0

1.1

—

31.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

427

3650

1.19

2.81

2.0

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.06

2.80

2.5

2.4

u/field

0.7

0.6

0.14

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.55

2.78

4.5

7.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

131

1.99

2.74

1.5

pmol/l

15.4

15.7

0.07

110

(3014051) Protein [Presence] in Urine by Test strip

922

0.66

2.74

2.3

2.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

181

1.83

2.73

1.0

1.1

99.2

92.9

0.51

142

(3028308) Erythrocytes [#/volume] in Pleural fluid

428

1.53

2.71

1.5

1.4

e6/l

37077.7

75160.1

0.85

245

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

104

1422

0.73

2.70

1.7

mg/l

4.1

3.2

0.32

1001

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

125

2.01

2.70

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

211

1.76

2.70

1.2

1.6

u/l

11.8

6.8

0.44

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

105

2.10

2.68

1.1

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

4.22

2.67

2.8

2.1

mg/l

3.4

2.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

169

1316

1.29

2.66

1.8

2.5

g/l

3.1

0.06

117

1051

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

108

787

1.38

2.66

3.2

1.9

nmol/l

0.8

0.08

666

(3004716) Salmonella sp identified in Stool by Organism specific culture

234

1898

1.24

2.64

1.5

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

183

1.81

2.64

3.3

3.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

258

1.67

2.63

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

480

1.49

2.63

1.5

1.3

nmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

176

1381

1.28

2.62

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

816

0.65

2.62

1.4

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

282

2336

1.22

2.62

1.3

au/ml

36.4

54.1

0.96

104

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

416

1.52

2.61

2.3

1.6

—

(3000492) Spirometry study

427

3676

1.18

2.60

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.67

2.59

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

385

1.54

2.58

1.4

mmol/l

6.3

6.4

0.02

357

(3000330) Specific gravity of Urine by Test strip

239

1949

1.24

2.58

4.8

3.2

—

(3028433) Virus identified in Specimen by Culture

114

2.02

2.55

1.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

149

1.88

2.55

1.3

1.1

iu/ml

189.0

197.5

0.08

149

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.60

2.53

1.4

nmol/l

850005.0

202571.7

—

(3035880) pH of Pleural fluid

217

1.71

2.47

1.4

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

381

1.53

2.47

2.6

3.2

60.4

58.7

0.18

233

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

251

2068

1.23

2.47

9.6

9.3

mmol/l

24.1

24.3

0.45

230

1942

(3016650) Hepatitis A virus Ab [Presence] in Serum

632

1.40

2.40

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

190

1525

1.26

2.38

4.3

3.9

mmol/l

24.7

24.8

0.14

175

1416

(3009214) Lutropin [Units/volume] in Serum or Plasma

137

1055

1.31

2.38

1.4

u/l

9.7

9.9

0.05

112

857

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.64

2.36

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.12

2.36

1.1

—

(40758558) Short blood count panel - Blood

1060

9759

1.11

2.35

8.5

6.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

346

1.54

2.34

1.2

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

104

772

1.35

2.33

1.7

1.4

u/ml

10.7

13.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

104

773

1.35

2.31

1.7

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

697

1.37

2.29

1.8

1.4

u/ml

107.2

115.3

0.51

152

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

230

1.66

2.29

1.4

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

223

1.66

2.27

2.7

36.3

38.4

0.33

(3006442) Creatine [Moles/volume] in Serum or Plasma

262

1.61

2.26

1.4

1.5

umol/l

69.7

71.9

—

(3019977) pH of Arterial blood

231

1.65

2.26

3.1

2.6

7.4

0.07

(3045788) Cell count panel - Pleural fluid

382

1.50

2.25

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

152

1198

1.28

2.24

2.7

2.3

89.4

90.8

0.30

139

1124

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

498

1.43

2.23

1.4

1.3

—

(3024263) Appearance of Synovial fluid

209

1.68

2.22

1.8

—

(3042733) HLA Ab [Presence] in Serum

128

1.88

2.21

4.4

4.7

—

(3024928) Oxygen saturation in Venous blood

108

815

1.33

2.19

5.6

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.62

2.18

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

2.18

3.0

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

644

1.37

2.18

1.7

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

399

3473

1.16

2.16

1.8

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

394

1.48

2.15

1.1

—

2.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

715

1.35

2.13

2.0

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.05

2.11

1.2

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.05

2.11

1.3

1.2

—

184.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

2.10

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

200

1641

1.23

2.10

1.3

1.4

iu/l

27.7

28.6

0.14

169

1401

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.20

2.09

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

198

1.67

2.08

1.5

1.2

nmol/l

139.3

135.7

0.18

198

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

2.06

0.0

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

146

1.79

2.06

2.5

2.1

—

(3008898) HLA-B27 [Presence]

161

1293

1.25

2.05

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.50

2.05

3.0

3.1

—

(40762365) Oxygen content in Arterial blood by calculation

2.18

2.04

2.9

2.3

ml/dl

14.8

15.1

0.18

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.63

2.01

1.1

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

1331

12486

1.09

1.98

3.0

2.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.34

1.96

2.0

2.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

345

1.48

1.96

1.3

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

2.03

1.95

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.03

1.95

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.03

1.95

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.03

1.95

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

504

1.39

1.94

1.4

u/l

26.7

27.4

0.07

418

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.97

1.93

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

226

1.60

1.93

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

459

4073

1.14

1.92

2.1

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

618

1.35

1.88

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

143

1.75

1.88

1.2

1.1

—

(3016228) CD19 cells/100 cells in Blood

151

1.73

1.86

2.5

2.1

6.4

9.6

1.29

146

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

260

1.54

1.86

1.4

u/l

12.6

13.0

0.19

250

(44806420)

107

1.87

1.86

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.39

1.85

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

245

1.56

1.83

1.9

2.5

e6/l

495.6

641.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.83

1.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.83

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

298

2574

1.17

1.82

2.5

2.4

au/ml

13.5

23.3

—

135

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

460

1.40

1.81

2.2

2.1

mg/l

23.0

22.1

0.07

107

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

230

1.57

1.81

1.1

ratio

1.0

1.1

0.80

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

270

1.52

1.81

1.5

1.1

—

27.2

—

(3037121) Protein [Mass/volume] in Urine

163

1333

1.23

1.81

3.5

3.0

g/l

0.4

0.3

0.50

553

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

211

1771

1.20

1.80

2.2

1.9

—

(3001729) Color of Synovial fluid

2.57

1.80

2.1

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

529

1.37

1.79

1.9

2.2

—

4.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

419

1.41

1.79

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

100

774

1.30

1.76

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

100

774

1.30

1.76

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.44

1.75

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

258

0.50

1.74

1.2

1.3

—

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

427

4783

0.88

1.72

4.6

4.5

31.0

32.1

1.29

293

3263

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

195

0.46

1.71

1.1

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.29

1.70

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.91

1.69

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

441

1.39

1.69

2.2

2.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.38

1.67

1.5

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

754

1.29

1.67

1.6

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

477

1.37

1.65

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

460

1.37

1.65

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.10

1.65

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

196

1.59

1.65

1.2

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

713

6554

1.10

1.64

3.1

2.7

e6/l

1.3

1.2

0.44

461

3704

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

461

1.37

1.63

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

470

1.37

1.63

1.4

—

(3017569) Oxygen content in Arterial blood

205

1.56

1.62

2.8

2.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

462

1.37

1.62

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.57

1.61

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

377

0.61

1.61

1.8

1.6

—

(3018133) Calcium [Moles/volume] in Urine

2.15

1.61

1.2

2.1

mmol/l

2.7

0.00

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

287

1.47

1.59

2.0

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

206

1.56

1.59

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

222

1897

1.18

1.58

1.1

1.0

—

(40768441) Liver Pathology biopsy report

279

1.47

1.58

1.3

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

159

1.64

1.58

6.1

5.9

mg/l

68.4

62.7

0.15

112

(3026480) Teichoate Ab [Titer] in Serum

2.69

1.58

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

141

1155

1.23

1.58

1.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.20

1.56

3.7

2.5

—

21.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

107

851

1.26

1.56

1.3

mmol/l

3.9

3.8

0.23

793

(1002224) Polysomnography panel

132

1610

0.81

1.55

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.11

1.55

1.2

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

119

961

1.24

1.53

1.3

mg/l

771.1

524.2

0.64

113

907

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

161

1.62

1.52

3.0

2.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.16

1.50

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

469

1.35

1.49

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

143

1182

1.22

1.48

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

203

1.53

1.45

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.45

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

241

0.54

1.45

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

138

1141

1.22

1.44

1.4

1.3

miu/ml

205.4

215.4

0.11

528

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

443

4005

1.12

1.42

3.6

4.1

ug/l

18.1

24.9

0.48

367

3242

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

1.53

1.42

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

413

1.36

1.42

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

111

1.71

1.38

2.1

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

145

1210

1.20

1.38

2.2

2.5

g/l

0.8

1.0

0.27

120

1044

(21494434) Karyotype in Bone marrow

330

1.40

1.38

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.00

1.38

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

643

1.28

1.37

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.94

1.36

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

769

1.25

1.35

1.2

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.87

1.34

7.4

7.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

394

0.66

1.33

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

798

1.25

1.33

1.7

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.72

1.33

1.1

98.7

91.6

—

(4094501)

1099

0.80

1.32

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

270

0.59

1.30

6.4

2.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.10

1.30

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.09

1.27

1.0

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.94

1.27

1.1

96.8

98.4

0.06

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.05

1.26

1.4

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

1.68

1.25

9.5

7.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

107

1.68

1.25

1.3

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

256

2259

1.14

1.25

1.9

1.6

—

(3025315) Body weight

2.40

1.24

6.8

3.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.67

1.22

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

373

1.34

1.22

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.63

1.21

1.6

1.2

—

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.63

1.21

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

101

1.69

1.19

1.3

1.2

ug/l

72.6

172.6

0.53

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

284

2534

1.13

1.18

1.2

iu/ml

103.1

146.0

1.55

100

913

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

264

1.40

1.18

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

264

1.40

1.18

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.70

1.17

10.1

7.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

376

1.33

1.17

3.9

3.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

385

1.33

1.16

2.4

3.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

223

1.44

1.16

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

429

1.31

1.15

1.4

1.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

30.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2572

25056

1.06

1.14

3.0

2.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1087

0.82

1.13

1.6

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

292

1.37

1.13

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

192

1.46

1.11

1.1

—

(3036489) Thrombin time

168

1455

1.16

1.10

2.6

2.1

21.2

21.5

0.42

137

1269

(3015076) Soybean IgE Ab [Units/volume] in Serum

160

1.50

1.09

1.0

u/ml

0.2

—

(3009871) Measles virus Ab [Titer] in Serum

120

1.59

1.08

1.8

1.7

—

(3042517) Benzodiazepines panel - Urine

2.19

1.08

1.4

2.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

244

1.40

1.07

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

830

1.21

1.07

2.4

3.5

u/ml

251.8

839.0

0.95

758

(4146454)

432

0.72

1.07

3.2

2.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

194

1.45

1.06

2.1

1.6

u/field

1.5

2.7

0.87

142

(3025130) Human papilloma virus identified in Specimen

477

0.73

1.06

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.62

1.05

1.1

1.2

102.5

89.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

125

1061

1.18

1.05

1.7

2.4

g/l

0.0

0.25

113

975

(3024932) HLA-DR beta [Type]

129

1.55

1.05

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

245

1.39

1.05

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.79

1.04

2.3

2.0

umol/l

15.9

17.2

0.18

(3020650) Glucose [Presence] in Urine

106

1.61

1.02

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

626

1.23

1.02

1.7

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

247

1.38

1.01

1.4

1.2

—

(3045716) Anion gap in Serum or Plasma

188

1.44

1.01

3.5

2.4

mmol/l

8.2

9.3

1.10

147

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.97

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

346

1.30

0.94

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

133

1.51

0.94

2.9

1.8

u/ml

307.4

25066.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

268

1.35

0.94

1.2

—

(4133840)

101

1.59

0.93

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

128

1103

1.16

0.93

1.5

2.4

g/l

37.5

37.6

0.06

106

959

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

145

1661

0.87

0.92

1.6

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

531

0.77

0.90

1.5

nmol/l

0.2

0.4

4.21

424

(3003338) MCHC [Mass/volume]

3336

33880

0.95

0.90

26.8

17.3

g/l

332.4

332.7

1.03

3310

33638

(3051101) Glucose [Moles/volume] in Cord blood

1.75

0.90

2.7

7.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.07

0.89

1.7

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

194

0.62

0.88

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.91

0.88

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

566

1.22

0.87

1.1

120.3

114.7

0.82

514

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

298

1.31

0.87

1.2

—

275.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

621

1.21

0.87

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

369

1.28

0.86

1.1

1.0

u/ml

0.1

0.33

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

632

1.21

0.85

1.1

iu/ml

161.9

15928.9

0.53

147

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.63

0.84

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

154

1.43

0.83

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

248

2252

1.11

0.83

2.3

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

580

1.21

0.82

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.81

1.0

1.1

—

(3024471) HLA-A [Type]

130

1.46

0.80

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

575

0.80

0.79

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

158

1403

1.13

0.79

2.6

3.5

u/ml

570.7

3013.5

0.68

141

1190

(4015189)

1.53

0.78

4.2

2.0

—

(40768800) Prostate Pathology biopsy report

901

0.84

0.78

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

768

1.18

0.77

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.77

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

573

0.80

0.77

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

853

1.16

0.76

1.4

e6/l

47.8

29.1

0.26

662

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

853

1.16

0.76

1.4

e6/l

2444.3

1172.6

0.38

700

(3033658) Prothrombin time (PT) actual/Normal

954

9944

0.95

0.75

5.2

3.9

86.8

89.5

2.54

919

9704

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

988

9484

1.05

0.75

3.1

2.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.08

0.74

1.6

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.74

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

193

1.35

0.73

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.00

0.72

1.2

1.1

u/l

—

6.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.00

0.72

2.2

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

107

0.56

0.72

2.5

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

264

0.72

0.71

1.9

1.7

—

(4306422)

573

1.19

0.69

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

112

983

1.14

0.69

1.2

1.1

—

(4281824)

382

1.23

0.69

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

1.41

0.69

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.53

0.68

2.3

pmol/l

64.4

74.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

161

1.37

0.68

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.63

0.66

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.51

0.66

2.1

2.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

282

0.74

0.65

1.1

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

121

1075

1.13

0.64

3.6

2.6

200.6

191.7

0.46

114

1027

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

207

1.31

0.63

1.1

u/l

77.9

84.6

0.21

177

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

207

1.31

0.63

1.3

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.50

0.63

1.4

3.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

460

1.20

0.63

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

315

1.24

0.62

1.3

titre

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

391

0.79

0.61

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

289

1.25

0.60

1.2

1.1

mg/l

30.9

43.4

2.46

239

(3047007) Chlamydophila sp Ab [Presence] in Serum

527

1.18

0.60

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.46

0.58

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

1.72

0.57

1.0

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

861

0.87

0.57

3.9

3.3

mg/l

27.1

26.9

0.02

533

(3000034) Microalbumin [Mass/volume] in Urine

392

1.20

0.57

3.1

2.9

mg/l

41.5

49.0

0.11

287

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.56

1.2

1.5

umol/l

56.5

46.4

—

(4035726)

361

3400

1.07

0.56

1.4

—

(3045424) Erythrocytes [Presence] in Urine

681

1.15

0.55

1.6

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

302

1.23

0.55

1.2

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.45

0.55

1.1

pmol/l

887.4

302.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

591

6177

0.95

0.55

3.4

2.9

e6/l

3.8

2.2

1.21

344

3352

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.46

0.54

2.8

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

205

0.73

0.54

2.7

2.1

ug/min

67.7

258.5

—

(3015183) Erythrocyte sedimentation rate

195

1.28

0.54

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

169

1.30

0.53

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

169

1.30

0.53

1.5

1.4

—

(3048879) Bone marrow aspiration report

108

1.39

0.53

1.4

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

278

1.22

0.51

1.1

mg/l

255.2

274.8

0.36

241

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

500

1.16

0.50

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.46

0.50

1.2

1.3

—

(3020491) Glucose [Moles/volume] in Blood

302

0.79

0.49

2.2

1.7

mmol/l

8.0

6.7

1.33

203

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

342

3615

0.94

0.49

2.9

2.4

u/l

37.9

52.2

0.54

300

3124

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

114

1030

1.11

0.49

1.3

—

(40757373) Influenza virus identified in Isolate

1.43

0.49

2.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

110

993

1.11

0.48

1.6

2.5

g/l

0.0

0.00

912

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

984

1.11

0.48

1.6

2.5

g/l

0.0

0.00

912

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

851

1.12

0.48

1.8

1.9

pmol/l

213.6

201.1

0.61

797

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

199

1.26

0.47

1.1

u/l

20.6

20.5

0.00

167

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.46

0.46

4.9

7.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1450

14180

1.03

0.46

4.5

4.9

ug/l

2.0

3.5

3.47

1293

12728

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

300

1.20

0.46

2.1

u/field

3.8

1.9

0.88

121

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

646

1.13

0.45

1.2

1.3

u/l

30.7

37.3

0.25

560

(3032057) Clostridioides difficile [Presence] in Stool

1.43

0.45

1.8

2.0

—

(4211845)

198

0.76

0.45

3.5

3.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

103

1.36

0.45

1.2

—

(3019225) pH of Specimen

401

3823

1.05

0.45

4.4

4.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

265

1.21

0.44

1.8

1.6

mmol/l

7.5

8.1

0.39

168

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

135

1241

1.09

0.43

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

640

1.13

0.43

1.1

—

(3019174) dRVVT (LA screen)

1.61

0.43

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.61

0.43

14.4

8.2

—

(37021550) Renin [Units/volume] in Plasma --upright

1.38

0.42

1.0

1.3

mu/l

115.0

62.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1108

11355

0.97

0.42

4.3

4.2

22.7

21.8

0.94

519

5541

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.1

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.1

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.1

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.1

1.7

—

(3005570) Glucose [Moles/volume] in Urine

397

1.16

0.41

3.3

1.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

232

1.21

0.39

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

368

0.84

0.39

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.43

0.39

1.4

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.43

0.39

1.2

1.1

u/l

20.6

25.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.43

0.39

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.39

0.0

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

10.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.39

0.38

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

181

0.77

0.38

3.5

3.1

—

(3002619) Bacteria identified in Specimen by Culture

1.32

0.37

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

179

1.23

0.37

1.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

179

1.23

0.37

1.1

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.35

0.37

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

114

0.70

0.37

3.1

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

534

1.13

0.37

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

346

3615

0.95

0.36

1.4

—

(3045414) Leukocytes [Presence] in Urine

168

1792

0.94

0.36

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.40

0.35

1.0

1.3

umol/24h

2.0

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

396

1.14

0.33

1.1

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

182

1.21

0.33

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

192

1.20

0.32

16.2

11.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

125

1166

1.07

0.31

1.7

1.8

nmol/l

39.5

41.3

0.42

120

1126

(3047189) Immunofixation for 24 hour Urine

183

1.20

0.31

1.3

1.8

—

(40768804) Tissue Pathology biopsy report

1608

15837

1.02

0.31

2.1

—

(40768793) Breast Pathology biopsy report

789

0.91

0.31

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

258

1.16

0.31

1.6

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

1.23

0.30

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.29

0.30

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1100

11209

0.98

0.29

1.5

1.4

—

(4027681)

222

1.17

0.29

1.5

1.2

—

(3049717) Cytology report of Urine Cyto stain

163

1541

1.06

0.29

2.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

110

0.73

0.28

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1452

14302

1.02

0.28

3.4

2.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.32

0.28

1.9

1.8

ug/l

2.8

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.29

0.28

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

343

0.87

0.27

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

195

1859

1.05

0.27

3.1

3.4

u/ml

71.9

58.4

0.32

190

1790

(3008536) Aspergillus sp Ab [Presence] in Serum

1.21

0.26

1.6

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.28

0.26

1.1

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.70

0.26

3.2

2.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

278

0.86

0.26

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

278

0.86

0.26

1.3

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

309

0.87

0.25

1.5

g/l

0.9

1.0

0.92

309

(4268621)

397

1.11

0.24

2.1

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

142

1.20

0.24

1.2

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

142

1.20

0.24

1.2

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

919

1.07

0.24

1.8

1.9

iu/l

4.4

4.8

0.10

329

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

275

0.87

0.23

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

275

0.87

0.23

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

143

1.19

0.23

1.2

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.28

0.23

1.8

2.4

—

(3051651) Icteric interference index of Serum or Plasma

228

1.14

0.22

5.7

3.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

172

1.16

0.22

4.7

1.9

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

387

0.90

0.20

4.9

3.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.20

0.0

1.4

—

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

3.7

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.20

0.19

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.19

3.0

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.15

0.19

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

203

1.13

0.19

6.1

u/ml

46.2

13221.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

249

0.88

0.19

3.7

7.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

217

0.88

0.18

1.3

1.2

—

(3002256) Pathology report gross observation

510

5205

0.98

0.18

1.2

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.21

0.18

3.1

1.9

pmol/l

61.6

34.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

166

1.15

0.18

1.1

—

(3022621) pH of Urine by Test strip

265

2576

1.03

0.17

3.9

2.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.13

0.17

1.3

1.8

—

(3011648) Oxygen content in Venous blood

320

0.91

0.17

4.2

2.3

10.0

11.2

0.86

320

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

278

0.90

0.17

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3656

36429

1.01

0.16

20.7

14.5

38.9

39.9

5.43

2157

26473

(40768795) Lymph node Pathology biopsy report

360

1.08

0.16

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.79

0.15

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

275

0.91

0.14

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

113

1.15

0.13

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

938

0.96

0.13

1.3

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

123

1.14

0.12

1.1

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

272

0.92

0.12

1.0

ng/l

40.7

44.4

0.16

182

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

143

1.12

0.11

3.1

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

100

965

1.04

0.11

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

271

0.92

0.11

1.0

ng/l

782.7

710.8

0.45

182

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

157

0.89

0.11

2.8

2.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

1.14

0.11

2.4

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.14

0.10

1.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.11

0.09

1.0

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.15

0.09

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

117

1138

1.03

0.09

3.7

3.3

—

(44806071)

1.04

0.09

1.0

1.1

—

(4024509)

360

0.94

0.09

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

268

0.93

0.09

1.0

ng/l

280.9

318.2

0.36

184

(3006270) Folate [Moles/volume] in Blood

321

1.06

0.09

1.1

nmol/l

365.1

377.7

0.11

279

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.78

0.08

1.0

ug/l

85.5

73.1

—

(3036603) Volume of Urine

254

1.06

0.07

1.4

1.5

2409.2

1888.6

0.79

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

589

1.04

0.07

1.3

1.2

u/ml

1.4

3.7

2.48

189

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

509

0.96

0.07

1.1

u/ml

10.0

3.4

0.56

245

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

571

1.03

0.06

1.3

1.2

u/ml

2.5

4.9

1.97

244

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

404

0.97

0.05

1.1

—

(3014271) Vancomycin [Susceptibility]

189

1.06

0.04

3.4

2.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

373

0.96

0.04

2.7

5.2

u/ml

409.4

65.0

—

111

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

113

1148

0.98

0.04

1.4

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

122

1.07

0.02

1.6

1.8

—

(3034426) Prothrombin time (PT)

138

0.94

0.02

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

117

0.94

0.01

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

213

1.03

0.01

1.6

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

213

1.03

0.01

1.0

1.1

u/l

0.9

1.1

—

101

(3017446) Testosterone [Moles/volume] in Serum or Plasma

318

3169

1.00

0.01

2.3

2.2

nmol/l

12.3

12.7

0.43

270

2789

(3045142) Bone marrow Pathology biopsy report

417

0.98

0.01

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3726

37269

1.00

0.00

17.9

12.8

ml/min/173m2

82.4

81.6

1.29

3200

30748

(3003129) Base excess in Capillary blood by calculation

102

0.98

0.00

1.4

1.8

mmol/l

-0.7

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

132

0.98

0.00

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

172

0.99

0.00

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

109

1.01

0.00

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

1.01

0.00

3.6

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

1.01

0.00

3.6

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

211

1.00

0.00

2.6

2.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

299

1.00

0.00

1.4

pmol/l

74.6

155.6

0.39

(3014891) Appearance of Pleural fluid

0.88

0.00

1.4

1.5

—

(3000285) Sodium [Moles/volume] in Blood

0.96

0.00

1.4

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.3

—

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

100

1.00

0.00

1.6

2.8

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1556.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

128.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.88

0.00

1.0

1.3

—

119.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.99

0.00

1.0

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.4

—

67.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_DERM and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.469 [1.34, 1.61]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 2882 out of 16388 females with L12_INFECT_DERM died.

Males

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.857 [1.71, 2.02]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.05

During the follow-up period (1.1.1998 — 31.12.2019), 4766 out of 17856 males with L12_INFECT_DERM died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_DERM.

N-year risk	Females	Males
1	0.141%	0.336%
5	0.862%	2.178%
10	1.864%	6.076%
15	3.692%	11.038%
20	6.611%	18.34%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_DERM – Infective dermatitis

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Infective dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints